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Abstract 
Live cell imaging to monitor biological oxygenation and respiration are on the cutting 
edge of bioanalysis, including cell metabolism, bioenergetics, mitochondrial function 
and drug toxicity studies. This thesis presents the development and evaluation of new 
luminescent sensors and probes, optimisation of the tumour spheroid model and the 
various applications for these in vitro tissues combined with novel O2 and temperature 
nanoparticle probes.  
Here a new method for O2 sensing was introduced, measuring extracellular 
oxygenation with solid state polystyrene scaffold (AlvetexTM) impregnated with the 
phosphorescent dye PtTFPP. We accessed the toxicity, sensitivity and photostability 
of the O2-sensitive scaffolds, as well as monitoring cell oxygenation following seeding 
with both PC12 and HCT116 cells. Using time-correlated single photon counting and 
phosphorescence lifetime imaging microscopy multiplexed with fluorescent markers 
and fluorescent staining we could non-invasively correlate lifetime values with 
toxicity and drug stimulation under mild imaging conditions (534 nm excitation, 650 
nm emission). 
Several novel O2 and temperature-sensitive nanoparticle probes were evaluated. These 
probes displayed sufficient brightness, photostability and sensitivity. Furthermore, 
they showed minimal toxicity and were capable of penetrating 3D tumour spheroids 
in depth, showing efficient staining and even distribution, an advantage over previous 
probes which had limited diffusion across thick biological samples.  
We applied the imaging methodology to the 3D spheroid model, investigating which 
method of formation from "free floating", "hanging drop" and LipidureTM, produced 
the most uniform, viable and metabolically active in vitro tissue. Probe staining 
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techniques were also optimised in the chosen spheroid model, ensuring monitoring 
gradients in various analytes was possible. 
Numerous applications were improved and aided by the new O2 measuring platforms. 
Combining the novel probes with our new 3D models we could monitor the effects of 
chemotherapeutic drugs in both seeded O2 scaffolds and 3D spheroids. The 
nanoparticles were used to demonstrate the application of FLIM method for multi-
parametric analysis of O2 simultaneously with temperature and confirm the existence 
of temperature gradients in the 3D cell-based model. Finally, we applied the O2 probe 
and its measurement via PLIM (phosphorescence lifetime imaging microscopy) 
method to elucidate the function of SPCA2 in human colon cancer HCT116 cells, 
grown in ambient and decreased O2 levels. We could correlate SPCA2 upregulation 
with hypoxia in both monolayer and in spheroids. Furthermore, we discovered that 
SPCA2 is up-regulated by cell density, playing a role in Mn2+ transport and cell cycle 
progression in cancer cells. 
Results show that the developed probes and techniques provide a useful tool for the 
highly sensitive imaging of intracellular and extracellular O2, temperature and other 
important parameters. The new improvements allow for cell metabolism and 
mechanistic studies, as well as enabling us to study cell/tissue adaption to hypoxia and 
drug stimulation.  
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Chapter 1. Literature Review, 3D tissue models, their uses 
as disease models and analysis by the fluorescence imaging 
method 
 
1.1 Introduction 
The cell constitutes the smallest, basic structural and functional unit of all living 
organisms, capable of replicating independently, often in the presence of neighbouring 
cells. Tissue is made up of a complex ensemble of similarly specialised cells and 
intercellular matter acting together to perform a specific function in the organism, with 
an organisational structure level intermediate between cells and a fully formed organ. 
Normal functioning of the tissue requires proper organisation and a healthy state for 
all its cells, while abnormalities in either of these features leads to a disease state. Cell 
models are too simplistic for gaining detailed understanding of a diseases effect on 
human tissue. Tissue models attempt to bring together single cells, forming structured, 
organised aggregates replicating the in vivo tissue microenvironment in vitro. 3D 
tissue models are useful in the study of cell metabolism and disease, mimicking the 
cellular interactions, signalling pathways and cellular morphology of natural tissues. 
They help elucidate mitochondrial dysfunction, drug delivery, disease mechanisms, 
cellular alterations and changes in gene expression, improving diagnostics and 
treatment and our overall understanding of tissue function.    
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1.2 Cell and tissue models 
1.2.1 Pitfalls associated with 2D monolayer cell cultures compared to 3D 
2D mono-layer is the most convenient cell culturing method, providing high viability 
and ease of use. 2D cultures are easier to manipulate, allow for the strict control of 
environmental factors and aid cell observation studies by conventional microscopy 
and biochemical assays. 2D models were instrumental in increasing our knowledge of 
cellular function, metabolism, signalling and many disease states. However, basic 2D 
monolayer cell cultures are poor models of the in vivo microenvironment. They are 
deficient in the extensive cell-cell and cell-extracellular matrix (ECM) signalling and 
prominent gradients of metabolites and bio-molecules typical for mammalian tissue in 
vivo. This limits the ability of 2D cultures to  mimic natural differentiation, 
proliferation [1] metabolism and physiology of cells within tissue [2-4]. The disparity 
in structure leads to striking differences in morphology and gene expression [5-7]. 
Mono-layered cells also lack the interplay associated with an active, complex stroma 
[8]. Physical cell differences include flattening, stretching and metamorphosis of the 
cytoskeleton as a result of being grown on the surface of a cell culture flask [9] (Fig. 
1.1). 2D proves to be a polarised model displaying a much greater number of binding 
proteins on the surface attached to the flask or dish [10]. Growth on a flat surface also 
ensures cells receive an even distribution of nutrients and growth factors from the 
media, an unrealistic distribution when compared to the natural gradients found in vivo 
[11].  
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Figure 1.1 Simplified comparison of 2D and 3D cell models.  
 
Furthermore, changes in the regulation of transcription and translation are associated 
with cell adaption to its new un-natural in vitro microenvironment. Gene expression 
studies with breast, colon and lung have shown that there are up to 30% of genes 
differentially expressed in cell lines compared to the original native tissue [12]. Genes 
of particular interest are those associated with negatively controlling proliferation, 
noticeably down-regulated in 2D culture. [11].  The continued use of 2D culturing in 
the drug development industry may hinder progress in the field [13]. The failure of 
some drugs to pass phase 3 has been attributed to the poor effect and lack of efficacy 
of the drug on the unnatural 2D monolayer micro environment [11, 14].  
Many of the pitfalls associated with 2D may be addressed by transferring studies to 
3D tissue models. 3D models ensure cells are more closely aligned to tissue, with a 
more uniform spread of adhesion molecules [15]. These models have normal cell 
shape, structure and function with minimal interference from external stimuli (Fig. 
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1.1). They allow cells to form complicated interactions increasing cell signalling, local 
gradients of bio-molecules and cell-cell communication. Additionally they reduce 
stresses and responses that arise when cell lines must adapt to a flat environment [9]. 
The discrepancies that exist between 2D and 3D cell culturing are clearly shown in a 
diverse range of studies some of which we highlight here. For example it was possible 
to reverse the malignant phenotype of human breast cells by introducing integrin-
blocking antibodies in 3D cell aggregates, a result not reproducible in the less 
physiologically relevant 2D cultures [16, 17]. Drug toxicity studies further highlight 
the importance of 3D structure and the heterogeneous microenvironment. Culturing 
cells in 3D tumour spheroids alters sensitivity to drugs, including cisplatin or 
doxorubicin [18]. This transformation in sensitivity can be attributed to the insufficient 
drug delivery [19], hypoxia experienced by cells in the spheroid core [20], cell-cell 
interactions aided by E-cadherin [21] and the production of extracellular matrix 
proteins combined with multi drug resistant pumps [22]. There are also those drugs 
which show greater effectiveness on 3D spheroids. PX-866 which inhibits PI-3 kinase 
subdues proliferation of the U87 glioblastoma, as well as HCT116 colon cancer cell 
spheroids [8, 23]. Significant differences in protein expression have also been 
observed in 3D cultures, compared to their 2D counterparts. Ovarian cancer cells 
cultured in 3D have exhibited a significant increase in the mRNA levels of α2/α5/β1 
integrins, a family of cell surface receptors as well as the protease MMP9 [24]. Protein 
expression changes have also been studied in non-cancer cell lines. The human 
submandibular salivary gland (HSG) has been transferred to 3D culture models to 
study salivary gland regeneration repair. HSG cells developed in 3D showed an 
increase in the production of acinar proteins, brought about via  translational regulation 
[25].   
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The number of unrelated studies, displaying contrasting results for 2D culturing 
compared to 3D, highlight the importance of using a more physiologically relevant 
cell model. The incorporation of 3D tissue models into biomedical research, 
regenerative medicine and basic cell biology [26] is spreading, aided by the 
advancement of modelling techniques ensuring ease of production, manipulation and 
as a result a closer representation of in vivo tissue. The versatility of 3D models is 
apparent, being used for identifying biomarkers in breast cancers, through co-culturing 
in laminin-rich extracellular matrix [27] and more recently drug development and 
testing [28]. The number and complexity of available 3D tissue models are increasing. 
They can however be  divided into two main categories, scaffold-based or scaffold-
free systems [26].   
 
1.2.2. Scaffold free models, spheroids  
Scaffold-free tissue culturing involves the creation of tissues through self-assembly 
and the formation of multi-cellular aggregates, with cells forming their own 
extracellular matrix components [9, 29]. One common scaffold-free model is the 
spheroid. The overall spheroid morphology and shape are dependent on the cell line 
used [11]. In a study of spheroid formation using a panel of 25 breast cancer cell lines 
four distinct types of spheroid structures were identified [30]. The first, round type, 
displays strong cell-cell adhesion, with the nuclei organised around the centre of the 
colony, often having a lumen form in the centre [31]. Mass-type spheroids are 
spherical in shape but the nuclei are no longer organised and they develop strong 
cellular communication. They are often larger than their round counterparts, and 
despite over-expressing luminal keratin 8 and keratin 18, they lack a lumen [11]. The 
‘grape like’ spheroid is loosely formed with less cell-cell interactions. The final type, 
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stellate, have cells with elongated bodies and invasive phenotypes, displaying the 
ability to bridge colonies and invade matrices [32].  
Several methods are available for spheroid formation. In the simple "hanging drop" 
method the cells aggregate spontaneously under gravity in the droplet of culturing 
media [2, 33, 34]. The  liquid overlay technique relies upon the suspension of cells in 
a non-adherent substrate, encouraging cells to aggregate and not attach [35] or growth 
of cells in stirring culture systems such as spinner flasks [36]. Spheroids may also be 
formed using non-adherent micro patterned surfaces [29]. The increased relevance of 
the spheroid model broadens its usage in high throughput screening of drugs and the 
production of complex tissue grafts [20, 37]. 
The ability of spheroids to mimic cell-cell and cell-matrix interactions, tissue 
contraction and condensation makes them useful for mechanistic studies. Thus, 
chondrocytes seeded in droplets to acquire the high density of chondrogenic 
condensations have been used to study the regulation of chondrogenesis by RAC1 and 
Cdc42 [38]. The role played by adhesion molecules may be examined in tumour 
spheroids which have shown greater resistance to some chemotherapeutic drugs 
compared to monolayer cultures. The expression of either the more prevalent negative 
E-cadherin or the wild type, in the form of Ewing Sarcoma tumour cell spheroids can 
decrease or increase  resistance to chemotherapy respectively [39]. Intracellular 
adhesion proteins connexins and pannexins have also been studied [40], revealing 
Panx1 accelerates the formation and compacting of spheroid culture and helps develop 
a more complete F-actin cytoskeleton [41]. Nemosis, the initiation of programmed cell 
death in the absence of apoptotic markers, has also been observed in spheroids [42].  
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While spheroid technology began as simple formation of cell aggregates it has 
developed towards fabricating more complex and physiologically relevant, tissue like 
structures. As tissues are heterogeneous, it is important to ensure that the 3D 
microenvironment accounts for complex structures, different cell types and their 
interplay. Tissue structures have been replicated in vitro in spheroid models, including 
pancreatic tissue [43], cardiac muscle [44] and pituitary glands [45]. Challenges in 
engineering such constructs relate to their size and the gradients of nutrients and 
oxygen (O2) in the tissue. Vascularisation of 3D tissue models and grafts can help to 
address this problem [46, 47]. The dense environment of co-cultured spheroids allows 
for the mimicking of the natural vascularised environment and thus support cell 
growth e.g. cardiac tissue [48], or pre-vascularised bone [49]. Simple vascular 
structures formed when spheroids  produced using human MSCs were co-cultured 
with human umbilical vein endothelial cells (HUVECs) [50]. The engineering of such 
vascular networks help the survival of implanted cells [51] and development of the 
spheroid model. Vascular architecture within these spheroids will also help mimic the 
endosteal niche in vitro [29].     
While vascularisation helps to improve the distribution of O2 and nutrients, the 
existence of a hypoxic core and naturally forming gradients within large spheroids can 
be advantageous in anti-cancer drug screening [52] and the study of cellular responses 
to changing O2 levels [53]. Spheroids are of particular interest in cancer research since 
they are made up of  proliferating cells on the periphery and quiescent cells at the core 
[54]. Cancer cells can adapt to this absence of blood vessels, O2, and nutrients by 
halting cell cycle progression and becoming dormant. This cancer cell dormancy can 
lead to anti-cancer drug resistance, as the primary mechanism of action for cytostatic 
drugs is to attack proliferating cells. Multicellular tumour spheroids, which have these 
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naturally occurring dormant regions have been utilised to identify drugs that 
specifically target the dormant inner core [20]. The formation of larger more robust 
spheroids can lead to formation of a necrotic core, mimicking more closely the 
conditions of tumours in vivo [55]. They have been used to culture cancer stem cells 
and investigate cancer relapse induction [56].  Human colon tumour spheroids have 
highlighted the changes in gene expression between 2D and 3D, with 3D spheroids 
maintaining CD133 expression and showing increased survival following 
chemotherapy-induced apoptosis [57]. Ovarian cancer cell spheroids have the ability 
to self-renew and possess a more aggressive invasive phenotype [58]. Hypoxic-
induced, cancer stem cell spheroid structures have been discovered in vivo, in the 
blood, contributing to metastasis [59].  Further development and improvement of 
spheroid models will no doubt ensure their continued use in biomedical research.  
 
1.2.3 Tissue slices  
Fresh tissue slices have been used to study individual tumour stages, grades and 
alternative slow and fast growing tumour subgroups [8]. The investigation of tissue 
responses to chemotherapeutic drugs and small molecule inhibitors have also been 
carried out [8, 60, 61], as well as identifying the location and migration of immune 
cells within tumours [62]. Tissue slices have been used as a platform for new anti-
cancer treatments including oncolytic viral infection and gene therapy [63-65].  
However, in order to maintain high viability, continued proliferation and tissue 
structure, slices can only be grown ex vivo for 3-7 days [8]. Even with the correct 
procedure for extraction and maintenance [66] this model displays high variability and 
inconsistency, even within tumours form the same entity [61] with noted changes in 
proliferation [67] and the overall cell make up [68]. This model also has problems 
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regarding the procuring of tissue material from patients and providing appropriate 
control samples [8]. The tissues are vulnerable to stresses and may lead to changes 
unrelated to the disease itself but because of surgery or handling, or changes in O2, 
temperature and nutrient availability during its slicing and maintenance. These factors 
may influence drug sensitivity and  results obtained while using them [8]. While the 
have their disadvantages tissue slices are not limited to tumour studies, with brain 
slices used extensively in scientific research, contributing massively to modern day 
neuroscience. They can usually maintain the architectural characteristics from the 
original tissue as well as preserving neurochemical activity and connectivity of 
synapses. Organotypic slice cultures have been taken from several brain regions, 
including the cortex, spinal cord and cerebellum [69].  However once again there are 
problems arising regarding slice preparation, with the “protective cutting” method 
leading to neuronal cell death, particularly in what is referred to as superficial layers 
[70]. The effect of this damage was apparent in a study carried out using 
thalamocortical slices from mice ranging from post-natal day 5 to day 20, monitoring 
the developmental decrease of neuronal chloride concentration. In contrast to the 
deeper in the tissue it was observed that there were elevated chloride levels in the 
superficial layers of the neocortical and thalamic brain slices in all ages, both 
susceptible to trauma. The possible reasons for this increase include disruption of the 
extracellular matrix and sectioning of neuronal processes [71]. 
Tissue slices derived from the liver, kidney and heart have also been used in several 
diverse studies. Liver slices were a popular in vitro model used to observe 
hepatotoxicity, testing the toxic effects of cocaine, endotoxin and paraquat to name a 
few. They also aided in research involving the metabolism of endogenous and 
exogeneous substrates, most notably caffeine metabolism. Furthermore, lipogenesis, 
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gluconeogenesis and ureagenesis were all investigated in the liver. Kidney slices have 
been used to look at renal responses to toxicants and renal metabolism, as well as being 
important models in transport studies involving the kidney. Heart slices are appealing 
for research as normal cell-cell interactions are maintained. They have been employed 
in assessing toxicant-induced injury to myocardial tissue. Ventricular slices aided in 
work involving mechanistic studies of sodium pumps, vital for the contacting of the 
heart. Other studies looked at the effect of diet and age on these pumps [72].  
 
1.2.4 Scaffold-based 3D models 
Scaffolds are specially designed materials engineered to form a desirable environment 
for cellular interaction, mimicking extracellular matrix, helping form new in vitro 
tissue like structures. Scaffold based models involve the seeding of cells on a 3D 
matrix or the spreading of cells in a liquid hydrogel, followed by polymerisation. The 
common scaffold components include natural materials such as collagen [5] or 
synthetic material including polymers [73]. The important characteristics required are 
compatibility with cell culture, low toxicity and adhesion sites for cell attachment. 
Natural materials already contain adhesion sites and biocompatibility, while synthetic 
materials have a definite chemical composition and may be modified for improved 
cell differentiation [74] or adhesion [75] and more reproducible framework. Scaffolds 
may be further sub-divided into either hydrogels or solid scaffolds. The hydrogel 
method involves the encapsulation of cells in a loose hydrogel comprised of cross 
linked materials including agarose and collagen [76]. Use of these structures should 
be confined to short experimental periods, due to the challenges associated with 
nutrient delivery [77]. Solid scaffolds also have their merits as a readymade support 
structure aiding cells in their creation of models akin to natural tissue. Cells are simply 
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seeded onto an open pores structure. These scaffolds are of particular use when the 
cells must form well defined architecture, with layers of alternating cell types, e.g. in 
artificial skin grafts, with the scaffold actively contributing to the creation of layers of 
epidermal and dermal tissue [9]. Osteon structures have been produced using scaffolds 
produced via the electro-spinning method [78] while more porous scaffolds have been 
employed in the growth of equine keratinocytes [79]. Scaffolds themselves tend to be 
either fibrous or porous in their structure.  Fibrous  scaffolds are prepared by delivering  
a polymer jet through an electric field, collecting the resulting structure on a chosen 
surface [80]. Porous scaffolds have pores of defined shape and size, which can be 
predefined, produced using the particulate leaching method. The polymer is caste 
around beads called porogens, often a salt or saccharide which latter dissolves leaving 
behind the desired pores. Pore size can have a major effect on growth, for example 
larger unconnected pores can lead to the development of a heterogeneous culture of 
isolated cells within the 3D microenvironment [9, 81]. Scaffolds manufactured using 
biodegradable materials like poly(lactic acid) and poly (glycolic acid) and their co 
polymers [poly(lactic-co-glycolic acid] have been applied to 3D modelling for tissue  
repair [82]. However, there is trepidation in their use for in vivo studies, as the 
degradation may lead to by-product release, adversely affecting the cells behaviour. 
Population of interior regions of scaffolds with cells is also challenging This problem 
may be overcome by using inert non degradable materials, such as 200 μm thick 
polystyrene membranes [83].  The sheer number of materials and production methods 
which can be combined and altered make scaffold materials a useful tool for in vitro 
tissue manufacture. 
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1.2.5 The future of 3D tissue models  
An exciting new advancement for 3D modelling is bio-printing, which involves the 
patterning of biological products including cells and bio molecules to produce tissue 
mimicking constructs [84-86].  3D bio-printing helps produce tissue mimicking 
constructs for transplantation [87],  3D heterogeneous structures for developmental 
biology [88] and drug screening [89], cellular and extracellular parts of a tissue 
through mimicking of specific cell structures and functions [86]. The earliest, method 
of bio-printing uses droplets to capture cells and non-living materials layered upon a 
suitable substrate [90]. This process can be carried out cheaply and with a high cell 
viability following printing. Laser bio-printing uses a laser beam to focus on a ribbon, 
exciting cells and collecting the 3D construct on a substrate facing the ribbon [91]. 
The extrusion method relies on an ejector system  in conjunction with a three axis 
robotic stage [92]. A piston is used to transfer bio ink onto the appropriate building 
substrate [87]. Mimicking natural tissue with these methods requires an in depth 
knowledge of the cells physiology and cell-extracellular matrix interactions [93]. 3D 
microenvironments are reconstructed using natural materials such as collagen and 
fibrin, synthetics including polyglycolide, polyethylene glycol or hybrids that combine 
both [86]. The creation of vascular grafts via printing negate some of the problems 
associated with nutrient and O2 diffusion. Vascular grafts have been printed combining 
multiple cell types including smooth muscle cells, endothelial cells and fibroblasts 
[94].  Bio-printing of skin tissue may be helpful in the development of topical drugs, 
studying of wound healing and dermal toxicology research [86]. An example of skin 
production was developed using fibroblasts and keratinocytes on a stable matrix using 
the laser method [95]. The printing of neural cells provides a model for new 
therapeutic approaches for Alzheimer's and Parkinson's [96] yet challenges remain due 
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to the complex nature of the multi layered brain, specifically in the medial and sagittal 
plane [97] Drug screening will no doubt benefit from 3D bio-printing, offering better 
predictive and cheaper results when compared to in vitro and animal screening. 
Furthermore it will provide the added incentives of personalisation of medicine and 
an increase in the number of drugs completing drug screening [86]. Drug screenings 
have been carried out using different bio-printing platforms including cell spheroids 
[98] and micro-fluidic systems [99]. In a more recent study a 3D lung for drug 
evaluation studies was produced using a valve based bio-printer [100]. 3D bio-printing 
has the potential to help make artificial tissue that is more physiologically relevant and 
will aid in improving our understanding of cell interactions and tissue formation.  
Spheroids will continue to be an important research model in the future, particularly 
with advances in combining multiple cell types. Culturing tumour cells together with 
fibroblasts, monocytes, embryonic bodies or endothelial cells allow for spheroids with 
stromal architecture to be produced [8]. Importantly, stromal cells play a major role in 
cancer cell development, being associated with cell-cell communication, tumour 
growth, metastasis [101] and mammary epithelial cells. Thus, spheroids produced 
from MCF10A (normal human breast epithelial cell line), human mammary 
fibroblasts (HMF) and human adipose-derived stem cells (hASCs) expressed much 
higher amounts of α-casein mRNA, hinting at its role in differentiation of mammary 
epithelial cells [102]. Stroma-derived micro-environmental cues can reduce the effect 
of anti-cancer drugs. To study this phenomenon spheroids were produced using DLD-
1 colon cancer cells combined with HS27A stroma cells. Results showed a reduced 
potency of the MEK kinase inhibitor Trametinib when compared to the control mono-
spheroid model [103]. In another study, colorectal cancer cells (HCT116) were 
combined with primary normal dermal fibroblasts to monitor differences in response 
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to electrochemotherapy.  Spheroids produced using only tumour cells were destroyed 
following electrochemotherapy, while those produced with normal cells survived. In 
the mixed spheroids only normal cells remained viable, with selective destruction of 
the cancerous cell line [104]. Co-culturing produces a more physiological model, 
showing promising results for drug stimulation studies. 
Further advancements in co-culturing and bio-printing will aid in the production of 
more complex 3D tissue models capable of accurately mimicking in vivo conditions. 
They will no doubt become more widely used, increasing our knowledge of cell 
metabolism and disease, signalling pathways, gene expression, cellular morphology 
and functioning of natural tissues.  
 
1.3 Live fluorescence imaging 
1.3.1 3D models and fluorescence imaging  
New in vitro tissue models must develop hand in hand with efficient new protocols, 
dyes and probes for their detailed characterisation, control or operation and analysis 
of cellular function during culturing. The list of key system parameters is large and 
includes O2, pH, and calcium (Ca
2+), viability, MMP, ROS, apoptotic markers, for 
which corresponding probes and measurement techniques are required. For multi-
cellular structures and 3D tissue models live fluorescence imaging is one of the main 
techniques, which allows real-time monitoring of such structures and individual cells 
within with sub-cellular resolution. Development of new instrumentation and 
microscopy integration has helped overcome challenges associated with high 
resolution imaging in complex, thick tissues with high light scattering [105]. 
Developments include super-resolution fluorescence imaging coupled with either 
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single molecules [106], or photoswitchable probes, achieving dynamic imaging of 
specific structures in live cells with 30-60 nm spatial resolution [107], or the use of 
deep-tissue fluorescence imaging with time-reversed ultrasound-encoded light, 
capable of imaging depths of up to 2.5mm in biological tissues and decreasing 
background signals [108]. Fluorescence imaging has been extensively used to study 
the differentiation of 3D-stem cell models [109], increase the depth at which thick 
biological samples can be imaged [110], monitor cell viability in multi-cellular glioma 
spheroids [111] and analyse drug therapies on organoids, enabling the prediction of 
drug responses in breast cancer [112].  
 
1.3.2 Principles of fluorescence, intensity, lifetime, FLIM and PLIM 
Luminescence is an all-encompassing term for the emission of light, not related to 
high temperatures. Processes included under this heading are chemiluminescence, 
bioluminescence, fluorescence and phosphorescence [113]. In this chapter I will focus 
on the latter two. Fluorescence is the method of energy dispersal for the lowest 
vibrational energy level of the first electronically excited singlet state back to the 
electronic ground state, through the emission of photons. Absorbed light is usually of 
a shorter wavelength than the emitted light with the difference between the exciting 
and emitted wavelengths called Stokes shift [114].  Fluorescent lifetime (τ), is the 
average time a fluorophore stays in the excited state following excitation, [115-117] 
with a duration in the nanosecond (ns) range [118]. Fluorescence lifetime imaging 
microscopy (FLIM) relies upon the principles of fluorescence (Fig. 1.2).  
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Figure 1.2 Simplified Jablonski diagram. 
 
Phosphorescence Lifetime Imaging Microscopy (PLIM) is like FLIM but uses 
phosphorescent dyes. While fluorescence emission stops as soon as the excitation 
source is removed, phosphorescence displays more prolonged, longer lifetimes, in the 
microsecond (μs) range. Phosphorescent compounds are capable of retaining energy 
longer than their fluorescent counterparts [118]. When excited by a laser pulse the 
electrons are excited to the higher singlet energy levels with a subsequent filling of the 
triple state using the intersystem crossing. The resulting lifetimes are longer as the 
transition from the triplet to ground state is  quantum mechanically forbidden, 
requiring a change of spin [119]. These processes are described by the Jablonski 
diagram (Fig. 1.2), with singlet and triplicate states indicated by S and T. The loss of 
energy non-radiatively from the excited fluorescent molecule via collisions with other 
molecules is referred to as dynamic quenching. This process provides us with the 
opportunity to accurately measure various analytes using either fluorescence or 
phosphorescence imaging. Fluorescence lifetimes decrease following collisions with 
different analytes as a result of the formation of metastable complexes, resonance 
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energy transfer or electron transfer [118]. In the case of O2, a primary by-product of 
this quenching is the singlet O2, a short lived O2 that usually returns to the ground 
triple state O2 (Fig. 1.2). However it may also affect other molecules, including the 
dye, lipids, proteins and affect measurements of samples when using the sensor [120, 
121].  
Fluorescence microscopy has become an indispensable tool in the study of biological 
pathways, cell behaviour and for the investigation of cell processes in animals and 
tissues. This is in part due to its compatibility with living cells and tissues and the 
minimal invasiveness of the technique.  The forerunner techniques in fluorescence 
imaging involve the use of confocal and wide-field microscopy, capable of resolving 
many of the cells organelles as well as providing information on other proteins and 
bio-molecules in the cell [122]. Widefield microscopy has developed through the 
improvement of microscope design, light filters, mirrors and objectives, aiding in 
faster detection of low-light fluorescence and improving greatly the signal to noise 
ratio. Widefield offers good XY dimension resolution and in most cases, requires the 
least amount of excitable light compared to other techniques, protecting the sample. 
Laser scanning confocal microscopy improves imaging resolution using beam steering 
optics, scanning mirrors and objectives which when combined focus the excitation 
light onto a specific region of the sample. Emission light is steered towards light 
sensing detectors through a pinhole, ensuring spatial filtering. The pinhole placed in 
the conjugate image plane to the focal point on the sample allows for optical 
sectioning, acting as a barrier to light coming from other focal planes. Confocal 
microscopy offers many advantageous additions including being compatible with 3D 
sectioning software, or facilitating data acquisition for techniques like Fluorescent 
Resonance Energy Transfer (FRET) and Fluorescence Recovery After Photobleaching 
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(FRAP) [123]. Fluorescence imaging can be conducted using either Intensity or 
Lifetime (FLIM/PLIM) imaging depending upon the required modality.  
Intensity measurements are the most simple and straight forward method for 
monitoring photoluminescence. There are however associated disadvantages. Factors 
affecting intensity signals include concentration of the dye or probe, the photo-
bleaching of the dye, auto-fluorescence and light scattering by biological samples, thus 
ensuring that its uses are primarily qualitative rather than quantitative. Optical 
interference, high light scattering and auto-fluorescence can all have drastic effects on 
the probes calibration in intensity mode, possibly leading to incorrect readings [120]. 
The improvement of intensity based measurements can be achieved using 'time 
resolved fluorometry' (TR-F), which fine tunes the signal-to-noise ratio paired with 
more reliable quantification and monitoring of the probes emission decay. This 
method measures luminescence intensity at specific times following a short excitation 
pulse. A delay time follows to extract the influence of short-lived scattering of light 
and auto-fluorescence after which the intensity signal is collected [120, 124, 125]. A 
corresponding simplified method referred to as rapid lifetime determination (RLD) 
[126], takes emission intensity signals (F1, F2) at two different delay times labelled 
(t1. t2) following the excitation pulse. Using these values, it is possible to calculate 
the lifetime of the probe using the following formula: 
𝜏 =
t2 − t1
In
𝐹1
F2
 
Fluorescence polarization anisotropy (FPA) is a technique used to study molecular 
interactions, enzymatic activity and for high throughput drug screening.  FPA relies 
on the fact that light emitted by a fluorophore has unequal intensities along different 
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axes of polarization i.e. the polarization of a fluorophore is inversely related to its 
molecular rotation, driven by Brownian motion, affecting the anisotropy/decay values. 
The anisotropy values are not dependent on the concentration of the fluorophore. FPA 
can be quantitatively measured by taking the difference of the emission light intensity 
parallel and perpendicular to the excitation plane, normalised by fluorescence 
emission intensity [127, 128].  
Although intensity measurements are useful a more advanced and accurate means of 
measuring fluorescence in complex biological samples is via fluorescence lifetime 
imaging. The advantage of lifetime imaging over the intensity imaging method is that 
results are not dependent upon the method of measurement. It is not affected by the 
excitation of the wavelength, light exposure or photo-bleaching as well as being 
independent of the intensity and concentration of the fluorophore [129].  
Luminescence lifetime refers to the average amount of time a molecule stays in its 
excited state before emitting a photon, returning to the ground state. The lifetime of 
the fluorophore is associated with the energetically unstable state and as such makes 
the fluorescence lifetime sensitive to external factors including temperature, polarity 
and the presence of fluorescence quenchers [118]. Often the energy absorbed with the 
photons is lost because of quenching i.e. the dissipation of energy, leading to a 
decrease in fluorescence lifetime. Quenching by environmental factors like 
temperature and polarity lead to adjustments in fluorescent lifetime through 
conformational changes.  An alternative means of quenching involves the reversible 
changes through electron distribution in the excited state [118]. Lifetime 
measurements can be classified into either phase modulation or time domain methods. 
Phase fluorimetry involves the excitation of a sample with an intensity modulated light 
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source at different time intervals with the emission phase shift (Φ) of the luminescent 
signal measured and used to calculate lifetimes using the equation: 
τ =
tan⁡(Φ)
2Пv
 
were v is the excitation frequency. There may be issues regarding auto fluorescence 
and light scattering when using this method for complex biological samples. Time 
domain technique involves the excitation of the chosen luminophore using short pulses 
to accurately measure lifetime values. It directly measures the dyes decay curve using 
a time gated detector, ensuring the detector gate time follows the excitation. Time 
correlated single photon counting (TCSPC) detects the arrival time of individual 
photons, emitted after a shirt surge of excitation, re-constructing a complete decay 
curve. This method provides high detection sensitivity, accurate lifetime 
measurements and when combined with confocal microscopy the ability to conduct 
optical sectioning [130].  
 
1.3.3 Fluorescent imaging dyes, probes, nanoparticles and biosensors 
A reliable fluorescent dye must possess a number of pre-requisite properties: high 
fluorescence quantum yield and molar extinction coefficient, long wave absorption 
and emission ranges, good photo-stability and selectivity [131]. Traditional xanthene 
dyes such as rhodamine B and Fluorescein-5-isothiocyanate (FITC) are used in many 
cell and molecule labelling experiments [131, 132], however the latter has low photo-
stability. This can be circumvented through the introduction of versatile substitutions 
to the original dye scaffold [133]. Thus, sulfonated rhodamine and cyanine dyes 
displayed increased brightness, hydrophobicity, stability in various pH and decreased 
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aggregation [131]. Newer dyes excitable in the Near Infra-Red (NIR) [700-900 nm] 
[134] range are useful for in vivo imaging due to the increased depth the fluorescence 
can penetrate the tissue sample, >100-300 µm in some cases [135, 136]. Cyanine dyes 
have tunable spectra ranging from 400-800 nm through the addition of vinylene units 
[131]. Difluoroboron dipyrromethene dyes (bodipy, 4-bora-3a,4a-diaza-s-indacene) 
also have this NIR range, good solubility and optical properties [133, 137]. The widely 
available methylene blue fluorophore used in the staining of tissues for fluorescent 
guided surgery [138] has low toxicity, water solubility and fluorescence in 600-900 
nm i.e. NIR range.  
The coupling of fluorophores with cancer-specific moieties, such as folate, cyclic 
arginine-glycine-aspartic acid (cRGD) peptides or antibody fragments [131, 139, 140] 
allows imaging of tumours in vivo. Some hepatamthine dyes, such as IR-808 and IR-
783, naturally accumulate in tumours even without chemical attachment of tumour 
specific ligands [141]. Other fluorescent probes only emit light or become active when 
they contact the target tissue under pre-ordained conditions [142]. The protease 
activatable Cy5.5-based fluorochrome is triggered when its non-fluorescent internal 
quencher is cleaved by the proteolytic enzyme, primarily located in the tumour [143-
145] producing the fluorescent signal in the tumour microenvironment.     
Nanoparticle-based (NP) fluorescent probes have advantages over small molecule 
dyes, particularly allowing incorporation of high concentration of fluorophores, 
increased retention in cells and reduced degradation. Furthermore, in NP structures, 
fluorescent reporter dye can be protected from interactions with the biological 
environment and can be coupled with targeting moieties. Fluorescent NP probes can 
be manipulated to ensure biocompatibility, biodegradability, low toxicity and 
improved signal-to-noise ratio [131]. NPs can be produced with known, specific 
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structure, composition and size and surface charge and chemical groups ensuring 
specific targeting and manipulation [146, 147]. Common polymers used in NP probes 
include poly(lactic-co-glycolic acid)(PLGA) and poly(ε-caprolactone)(PCL), both 
displaying biocompatibility and stability [131], and functional groups for dye 
attachment, such as chinosan [148, 149].  
Techniques used to embed fluorophores in the NP structures include the physical 
trapping of the dye molecule into the hydrophobic core. Another method involves in 
situ polymerisation of monomers in an emulsion which creates nanostructures. 
Emulsion polymerisation works by forming oil droplets containing  the monomer units 
that are then stabilised in water by surfactants [150].  The covalent attachment of the 
fluorophores to the polymer backbone ensures no leakage as well as reproducible dye 
loading into nanoparticles [131].  
Several key parameters determine NP behaviour and analytical performance as probes. 
Size is important, with small diameter of less than 30 nm showing efficient cell uptake 
but a risk of being cleared from the cell. Larger sized nanoparticles >200 nm show a 
decrease in cell internalisation and accumulation in the liver and spleen [151]. Shape 
can also affect the uptake of probes into cells, with rod shaped nanoparticles entering 
cells quicker than spherical ones [152].  The nanoparticles surface must also be 
considered, regarding its charge, hydrophobicity, ligand and polymer attachments 
which will affect the interaction of the probe with cells and its surrounding 
microenvironment [131]. Particles with a positive charge have been shown to have 
higher uptake into cells via endocytosis due to increased interaction with the 
negatively charged cell membrane, but have disadvantages including non-specific 
interactions and localising in undesirable locations within the cell [151, 153]. 
Negatively charged nanoparticles avert problems with non-specific interactions but 
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have a lower  cellular uptake [153]. Like negative nanoparticles, neutral nanoparticles 
have lower cellular uptake when compared to positive nanoparticles as a result of 
reduced interactions with the cell membrane [153]. Fluorescent dyes for imaging have 
shown to be more effective with improved results when introduced to NP.    
 
1.4 Fluorescent markers/probes for metabolic processes 
Fluorescent/phosphorescent lifetime and intensity markers and probes have been used 
extensively in the field of metabolic imaging. They are being applied to measure the 
distribution of numerous important analytes within cells and tissues including O2, Ca
2+ 
and NADH as well as having the capabilities to monitor changes in temperature and 
pH. These parameters are closely linked to this thesis material and will be covered in-
depth in this introduction. It is important to highlight, fluorescent sensors are not 
limited to these examples and are capable of measuring many other molecules 
including glucose [154] and lactate [155]. Fluorescent nanoparticles, produced using 
organic fluorophores in a polymer matrix are important in the fields of in vivo cancer 
imaging [131], disease diagnostics, use as chemo-sensors and for monitoring 
environmental changes [156]. FRET (fluorescent resonance energy transfer) based 
sensors rely on the principle that energy can be transferred from a donor to an acceptor 
molecule if the donors’ emission spectrum overlaps with that of the acceptor excitation 
spectrum. The have proven to be popular, being used as indicators for protein 
interactions [157]. 
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1.4.1 Fluorescence-based pH probes 
Cytoplasmic pH is highly regulated in eukaryotic cells, maintained at between 7.0-7.4 
via an ion transport system and the cytosols ability to act as a pH buffer. pH is of 
utmost importance for enzyme activity, each having an optimum in which they 
function most efficiently, for example phosphofructokinase, the rate limiting enzyme 
in glycolysis increases its activity significantly with a small rise in pH [158].  It has 
also been shown to be critical for controlling cell cycle and as a result the proliferation 
of cells [159]. Abnormal pH leads to improper cell functioning, growth and division, 
being implicated in common diseases like cancer, and Alzheimer's [160], with the an 
increase by a minimum of 0.4 pH units observed in multi-drug resistant cells [161]. 
An increase is also observed in DNA and RNA production following a rise in pH 
within the physiological range [158]. The numerous cellular functions controlled by 
pH make it a prime candidate for probe development, to more accurately measure its 
changes within cells. Fluorescence lifetime imaging can be used to determine pH 
values in cells and tissues, as the protonation of the fluorophore can lead to shifts in 
lifetime values. However, issues arise as the fluorescence lifetime of many 
fluorophores are not sensitive to change in the pH region (pH 4.8-7.4) seen in normal 
cells. Exceptions include fluorescein based indicators, such as 2',7'-bis(2-
carboxyethyl)-5-(and-6)-carboxyfluorescein, displaying lifetimes ranging from 2.75-
3.9 ns for pH 4.5-8 respectively [162, 163]. Fluorescent imidazoles lifetimes range 
from 0.3-0.5 ns, for their protonated and deprotonated states [164]. These fluorophores 
can be utilised for both ratiometric and direct pH measurement following calibration. 
Recently acid sensitive fluorescent nanoparticles which emit in the near-infrared 
(NIR) have also been shown to have pH sensitive lifetime values in the physiological 
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range [165]. The fluorescence based NIR probe LS482 displays  pH sensitivity and 
distinct lifetimes for both acidic and basic conditions [162]. 
Polymer microcapsules containing SNARF-1-dextran, a pH sensitive conjugate have 
been successfully introduced to both MB-435S breast cancer cells and NRK 
fibroblasts, via adsorptive endocytosis, before storing them in endocytotic vesicles. 
SNARF-1 has a pH-dependent emission shift, shifting from green to red fluorescence 
in acidic and basic conditions respectively, allowing for measurements of pH in the 
range 6-8. These microcapsules enabled monitoring of pH changes from the cell media 
(alkaline) to the endosomal/lysosomal cellular compartments (Acidic), with minimal 
toxicity upon internalisation of the capsules into the cells [166]. SNARF has also been 
used in numerous other biological studies measuring intracellular pH, introduced into 
many cell types including lymphocyte murine B cell line A20 [167], single type-1 cells 
isolated from the carotid body of neonatal rats [168], and adult cardiac myocytes [169] 
to name a few. 
Further works produced fluorescent pH indicators displaying high stability as well as 
emission in the NIR, produced using BF2-chelated tetraarylazadipyrromethene dyes 
(BODIPY). The emission in the NIR has many advantages, reducing background 
signals and auto-fluorescence, lowering light scattering in samples as well as 
increasing the penetration depth at which the probe can be imaged  [170]. More 
recently further BODIPY based fluorescent pH probes for bio imaging have been 
developed, displaying long wave emission in the far-red and NIR spectral range (650-
900 nm). The dyes are highly fluorescent, have intense absorption and high fluorescent 
quantum yield, are insensitive to polarity and pH and display good photo-stability 
making them ideal for biological studies. Thus, far red and NIR probes based on 
BODIPY dyes have been designed for common targets including pH, metal ions, and 
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oxidant species. These pH-sensitive probes have a proton receptor , usually a N-
alkylated moiety, which acts as an electron donor, quenching the fluorescence lifetime 
via photo-induced electron transfer (PET) or intra-molecular charge transfer  ICT 
[171].  These studies demonstrate the value of using fluorescence imaging as a 
reporting method to both monitor and explain pH mediated events within cells.   
 
 1.4.2 Fluorescence based NAD/NADP probes 
NADH and NADPH are the major endogenous fluorophores present in cells, playing 
a role in cell metabolism, reductive biosynthesis, cell signalling, immunological 
function, aging and apoptosis. In broad terms, NAD+ is primarily involved in 
regulating energy production, driving ATP generation in the cytosol by glycolysis and 
in the mitochondria via oxidative phosphorylation, while NADP+ is primarily involved 
in antioxidant defence and free radical generation. Both act as "electron carriers". 
Defects in these pathways can lead to diabetes, neurodegenerative diseases and cancer. 
Because of this, the measurement of the reduced forms NADH and NADPH can be a 
good indicator of the functional status of the cell and tissue. Both possesses their very 
own intrinsic fluorescence due the presence of fluorescent biomolecules [162, 172]. 
In many cell types the pool of NAD is larger than NADP. NADP as an electron donor 
is mostly needed in a reduced state ensuring a high NADPH/NADP+ ratio, while NAD 
an electron acceptor is maintained in an oxidised state with a low NADH/NAD+ ratio. 
Issues arise however as the light absorption properties of NADH and NADPH are 
identical, with a spectral peak at 340 nm, and emission spectra at 460nm, which give 
a combined signal often referred to as NAD(P)H. Thus, they cannot be distinguished 
based on fluorescence lifetimes, however steps are being taken to find FLIM based 
methods for separating the two. It was shown that enzyme-bound NADPH has a much 
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higher lifetime value than enzyme bound NADH. From this it was determined that 
bound NADH and bound NADPH have finite, distinct lifetimes in the cell with the 
relative contribution of each cofactor in the combined fluorescence signal could be 
calculated. Using two-photon excitation at 700 nm and a 435-485 nm detection 
window, the intracellular fluorescence lifetimes of NADH and NADPH were 
predicted to be 1.5±0.2 and 4.4±0.2 ns respectively, a pattern that was seen across a 
number of cell types including isolated ventricular cardiomyocytes and neurons in 
culture or brain slices [173]. It must also be considered that imaging of NAD(P)H may 
require either a UV laser or two-photon excitation, as a result of their blue-shifted 
absorption wavelength [172]. The ratio of NADH/NAD+  is key to understanding the 
redox state of cells and tissues, shown to be important in regulating numerous 
enzymes, such as dehyrogenases, polymerases and ADP-ribosyl cyclases [174]. Very 
recently genetically encoded fluorescent probes have been created that can measure 
the NADH/NAD+ redox state. This was made possible using the Rex family of 
transcriptional repressors, which are extremely sensitive to deviations in NADH in 
cells, allowing for the measurement of NADH/NAD+ ratios in both the mitochondria 
and cytoplasm [174]. NAD+ also acts as an essential substrate for sirtuins and 
poly(adenosine diphophate-ribose) polymerases, enzymes localised in the nucleus, 
cytosol and mitochondria, with fluctuations in NAD+ regulating their activity. To 
monitor the changes in free NAD+ a fluorescent biosensor has been developed [175], 
made up of a fluorescent protein (cpVenus) combined with a NAD+ binding domain, 
that uses NAD+  as a substrate exclusively. When the NAD+ binds, it decreases 
fluorescence in a dose dependent manner, a process which is also reversible increasing 
fluorescence upon elution of NAD+. This new probe was used to monitor the pools of 
NAD+ and dynamic changes in the nucleus, cytoplasm and mitochondria of both 
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HEK293T and HeLa cells [175]. Measuring the amount of reduced NADH inside the 
mitochondria can act as an indirect method for evaluating O2 supply within cells [176]. 
The NADH auto-fluorescent signals [177, 178] change as a result of O2 deprivation, a 
phenomena measured in monolayer single cells, tissue slices and in vivo [176]. As an 
indicator of O2 supply, NADH auto-fluorescent imaging has aided studies looking at 
the adverse effect on epidermal cells from ex vivo human skin following O2 
deprivation [179]. Using the less harmful method of Two-photon excited fluorescence 
(TPEF) in the near infrared spectrum it was possible to increase both deeper 
penetration for in vivo measurement of mitochondrial NADH fluorescence as well as 
allow for lengthier imaging sessions. This aided the study of how protein bound and 
free NADH behaved in rat skin following ischemia [180]. Both NAD+ and NADP+ are 
crucial to many important cell pathways and as such it is of great importance to 
produce probes capable of measuring them individually. Great leaps forward have 
been made in this regard using new fluorescent based probes and methods. 
 
1.4.3 Fluorescence based temperature probes 
The maintenance of temperature within cells is vital for the governing of almost every 
cellular biological interaction [181-183]. Temperature distributions within a cell can 
be an indicator of the thermodynamics and cellular functions of different cell 
organelles [184]. A rise in cellular temperature as heat production increases in 
cancerous cells is a common occurrence [185]. In contrast to conventional 
thermometers, measuring temperature using fluorescent probes provides a promising 
new method for analysing the distribution of intracellular temperatures and studying 
temperature dynamics at a molecular level [186-188]. Probes developed for this 
purpose must satisfy several criteria to be deemed successful, including high 
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temperature resolution, high brightness, biocompatibility, display stability with no 
changes in lifetime because of pH or surrounding bio molecules and concentration. 
This decreases the number of viable candidate probes that can efficiently measure 
intracellular temperature distribution [189]. Thermal infrared imaging systems [190] 
are useful in medical imaging but have limited spatial resolution. Fluorescence 
imaging and T-sensing probes can overcome these limitations ensuring quantitative 
measurement and imaging of cell and tissue gradients in real time in 2D and 3D [66, 
191]. Recently several optical sensors capable of measuring temperature using 
fluorescent signals have begun to emerge.  A newly developed fluorescent polymeric 
thermometer (FPT) has been shown to be photostable, cell permeable and capable of 
monitoring temperature (25-40 oC range) in many mammalian cell lines including 
HeLa, COS7 and NUH/3T3 via FLIM. The probe relies on a poly(N-n-
propylacrylamide) (polyNNPAM) temperature sensitive unit, an ionic (potassium 3-
sulfopropyl acrylate, SPA) and a water-sensitive fluorescent unit (N-(2-[(7-N,N-
dimethylaminosulfonyl)-2,1,3-benzoxadiazol-4-yl](methyl)amino) ethyl-N-
methylacryamide, DBD-AA). The polyNNPAM unit has an extended confirmation 
due to hydrated amide linkages at low temperatures, which weaken and shrink at 
higher temperatures, while the DBD-AA fluorescence is quenched in the presence of 
water molecules. Thus, the fluorescence increases at higher temperatures. The SPA 
unit increases hydrophobicity, preventing aggregation of the probe in cells. The FPT 
successfully entered the cells and diffused throughout, including the cytosol and 
nucleus. It did however show cytotoxicity at high concentrations, inhibiting cell 
proliferation and cell adhesion [192]. 
Intracellular temperatures have also been measured using green fluorescent proteins, 
ensuring biocompatibility, high resolution imaging and fast read out. The concept 
41 
 
upon which this GFP measurement is based is the measurement of fluorescent 
polarization anisotropy (FPA) [193]. Fluorophores illuminated by linearly polarized 
light re-emit some polarised fluorescence as a result of the random orientation of the 
molecular dipoles [194]. Increasing the temperature leads to acceleration of the 
Brownian rotational motion, a subsequent loss of memory of the incident light 
polarization and thus an increasing number of re-emitted photons. This in turn causes 
a decrease in PFA [193]. In short increased temperatures decrease anisotropy, with 
much more emission light intensity being lost to rotation. By transfecting live HeLa 
and U-87MG cancer cells with GFP, non-tagged proteins throughout the entire cell, it 
was possible to map temperature during and following stimulation using a heating 
laser. This method shows potential for studying the heating changes that occur during 
cellular processes at a single cell level [193].  The fluorescent dye rhodamine is 
sensitive to changes in temperature as well as displaying high brightness and excitation 
bands in the visible range [195, 196]. The most popular dye used in laser-induced 
fluorescence (LIF) temperature measurements is rhodamine B (RhB), predominantly 
used in micro-fluidic systems [197, 198]. Fluorescence lifetime change in response to 
temperature are due to a drop in rhodamine B emission quantum yield as temperatures 
increase, caused by the rotation of the diethylamino groups present on the xanthene 
ring [196, 199]. The measuring of temperature with RhB probes is made possible via 
emission lifetime measurement or ratio metric evaluation using intensity values [200].  
The temperature sensitive rhodamine B dye has been incorporated into latex particles, 
displaying high fluorescent signals, with a linear and reversible calibration for 
temperatures in the range 30-50 oC. These nanoparticles show promise in the study of 
temperature changes in biological, micro-fluidic and micro-electrical systems [196]. 
RhB due to its non-toxic effects in concentrations of around 40 nM [200] has also been 
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used to measure the temperature changes that occur in rat tendons following 
stimulation with radiofrequency radiation [201].  
FLIM has also been utilised to directly monitor temperature changes within cell 
organelles using both the small molecule-based fluorescent thermosensor comprised 
of the small molecule ER thermo yellow (compound BDNCA346) [202] and the 
fluorescent protein mCherry. ER thermo yellow specifically locates to the ER, and 
proved to be cell permeable, photostable, is independent of pH and viscosity and 
doesn't aggregate making it possible to measure Ca2+-induced heat production in real 
time in microtubules. The lifetime of the ER thermo yellow sensor decreased with 
temperature increase when measured in HeLa cells between 23-40 oC, forming a linear 
relationship between temperature and lifetime [202]. Expressing mCherry via 
transfection was used to examine temperature changes in the cytosol of C2C12 
myotubes. Like the ER thermo yellow the mCherry has a linear relationship between 
fluorescence lifetime and temperature. However ER thermo yellow displayed 
advantages over mCherry including higher incorporation into cells, with mCherry 
showing low expression efficiency [203].   
While new T probes look like a promising method for temperature measurement, their 
performance is still being compromised by aggregation, cross sensitivity, poor cell 
staining, viscosity and unstable calibrations. This can lead to misrepresentation of 
temperature gradients, making it necessary to carry out strict evaluation of possible 
measurements in cross interference in newly developed probes with various biological 
models. 
 
43 
 
1.4.4 Monitoring intracellular calcium  
Ca2+ present in both the cytosol and different cellular organelles including golgi and 
endoplasmic reticulum (ER) is important for intracellular signalling pathways. It is 
stored primarily (95%) in bone with the other portion (5%) in dynamic equilibrium, 
ensuring cellular Ca2+ homeostasis. Ca2+ is involved in charge transfer across 
biological membranes through functioning of ion channels, in microtubule assembly 
and disassembly by inducing microtubule depolymerisation, and acts as a positive 
modulator of epithelial and mesenchymal cell proliferation by regulating DNA 
synthesis. Ca2+ is also critical in cell-cell adherence, muscle contraction, metabolic 
regulation and ensuring communication between cells is possible [204]. There is a 
10,000-fold gradient of free Ca2+ that exists across the plasma membrane and similar 
gradients between ER compartments and the cytosol. Cytosolic Ca2+ signalling 
cascades involve the rapid movement of Ca2+ ions down an electrochemical gradient 
across the plasma and ER membranes. Ca2+ entry to the cell is mediated by numerous 
Ca2+-permeable channels including voltage-gated L-type and transient receptor 
potential channels with gating mechanisms including ligands, mechanical stress and 
temperature changes channels. Ca2+ mobilization is mediated by two families of Ca2+ 
release channels, the ryanodine receptor (Ryr) and inositol 1,4,5-trisphosphate 
receptor (IP3R). ER depletion stimulates store operated Ca
2+ entry, mediated by 
STIM1 on the ER and Orai1 on the plasma membrane. Ca2+ homeostasis is achieved 
by extrusion across the plasma membrane by Na+/Ca2+ exchangers and Ca2+-ATPase 
and resequestration into the store by the ER Ca2+-ATPase [205]. 
Hypoxia leads to an increase in Ca2+ concentration in the cytosol. This increase is 
brought about by several pathways including voltage-operated Ca2+ channels, reverse 
mode of the plasma membrane Na+/Ca2+ exchanger and through a non-specific 
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membrane pathway [206]. Hypoxia in cells also leads to membrane depolarisation, 
increasing intracellular Ca2+. This is mediated by inhibition of the O2-sensitive 
potassium channel, Kv1.2 and the up-regulation of the α-subunit of the Kv1.2 channel 
or K+ channels such as Kv1.5. The depolarisation induced inhibition of the Kv 
channels activates voltage-gated Ca2+ channels, leading to an increase in [Ca2+]1 [207].  
Ca2+ signals are produced by sudden increases in Ca2+ ion concentration inside cells. 
One of the most important things to consider when selecting a Ca2+-sensitive dye is its 
affinity for Ca2+. The dissociation constant (Kd) must be selected as appropriate for the 
concentration of Ca2+ in specific compartments. For cytosolic Ca2+ measurements, 
where values of 100-1000 nmol L-1 can be expected, a dye such as fura-2 with a Kd of 
225 nmol L-1 is needed. However for measuring Ca2+ in the ER where the 
concentration will be approximately 50-300 µmol L-1, dyes like Mag-fura with Kd 
values of 30-50 µmol L-1 are better [208]. Ca2+ indicators capable of fluorescence  
constitute the largest single application of fluorescence detection in living cells [209]. 
Fluorescent imaging coupled with fluorescent Ca2+ indicators advanced the field of 
research of the Ca2+ signalling pathway with a high degree of spatial and temporal 
resolution. These imaging approaches have been used in numerous tissues, organs and 
animal models, reviewed extensively in [210-213].  
Fluorescent Ca2+ indicators are based on genetically encoded fluorescent proteins 
[214] or small fluorescent organic molecules [215]. Many of the dyes on which these 
probes are based emit green fluorescent signal, including  Oregon Green 488 BAPTA-
1 and calcium Green-1 [216]. BAPTA a chelating group has high Ca2+ binding affinity, 
which following fusion to a fluorophore producing a fluorescence spectral shift in 
response to ion binding without diminishing binding affinity [209].  Ca2+ probes that 
emit red fluorescence include Rho-2 based on a rhodamine derivative [217]. These red 
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emission probes based tend to locate to the mitochondria due to their cationic nature 
limiting measurement of Ca2+ changes to mitochondria only. New fluorescent probes 
have been developed that emit in the red spectral region, displayed high cell membrane 
permeability and high fluorescence and also has the ability to measure cytoplasmic 
Ca2+ [216]. Another FLIM base probe capable of measuring intracellular Ca2+ is called 
G-CaMP, based on a single green fluorescent protein (GFP) molecule with a high 
affinity for Ca2+. The probe contains calmodulin, which when bound to Ca2+ 
undergoes a conformational change, changing fluorescent intensity signals. The probe 
itself displayed a high signal-to-noise ratio, capable of measuring dynamic 
intracellular changes of Ca2+ [218, 219]. This original sensor has since under gone 
many upgrades, improving its quantum yield [220] and signal to noise ratio [221]. 
The most popular FRET based sensors for Calcium sensing are the Cameleon sensors. 
They are made up of the calmodulin protein, fused to the calmodulin-binding domain 
of myosin light chain kinase M13 placed in between two fluorescent proteins like CFP 
and YFP. When calcium binds to the calmodulin it induces a conformational change, 
the M13 chain then binds to the calmodulin protein ensuring the two fluorophores are 
close enough to transfer energy. Other FRET based sensors use Troponin C as the 
calcium-binding moiety. Troponin C is selectively expressed in skeletal muscle cell; 
thus, it doesn’t influence normal cell processes when introduced to cells not derived 
from myocytes. The TN-L15 sensor is made of a chicken skeletal muscle Troponin C 
segment in between the fluorescent proteins ΔC11CFP and YFP. To improve the 
efficiency of energy transfer, 14 amino-acids of the N-terminus of the Troponin C 
fragment were removed. Binding of calcium to the binding sites lead to a 
conformational change, bringing the fluorophores close together, again allowing the 
transfer of energy. The FRET biosensor called mTFP-TnC-Cit was constructed by 
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replacing the CFP fluorophore within TN-L15 with mTFP1. This addition ensured the 
FRET sensor fits well to a two-component donor fluorescent decay model allowing 
easy fitting, less sensitivity to changes in environmental factors like temperature or 
emission wavelength, making it more suitable for FLIM experiments compared to 
CFP-based probes [222].  
The wide use of fluorescence based imaging methods has ensured great leaps have 
been made in the knowledge of Ca2+ signalling pathways and the role of Ca2+ dynamics 
within the cell. 
 
1.4.5 Phosphorescent O2 dyes, sensors, probes  
O2 is required for the production of cellular energy reserves via ATP formation, energy 
required for many cellular enzymatic reactions and physiological functions [223]. A 
decrease in the concentrations of O2 or an imbalance between the available O2 and cell 
consumption can lead to disease and a decrease in cell/tissue viability [224]. O2 can 
be considered a marker of cell viability and metabolic activity in cells and organisms 
that consume O2.  The most popular and widely used O2 probes rely on the 
measurement of photoluminescence, specifically phosphorescent signals in relation to 
O2 quenching. These probes are continually being developed and improved due to the 
high demand for monitoring in vitro and in vivo O2. Quenched phosphorescence 
imaging for O2 measurement has seen an increase in its popularity as advances have 
been made in synthetic, polymer chemistry, fluorescence, spectroscopy and optical 
and bio imaging [225]. Quenching-phosphorescence O2 detection is based on the 
direct, non-chemical and reversible quenching of phosphorescent signal because of the 
collision of the phosphorescent dye and O2 molecules. Quenching of the dye molecules 
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reduces the phosphorescence lifetime in a concentration-dependant manner [225]. The 
O2 sensitive materials are often based on synthetic indicator dyes including 
macrocyclic complexes of heavy metal ions with lifetimes in the microsecond (µs) 
range [226-228]. There are numerous different indicator structures for O2, the most 
dominant structures are a small number of dyes, displaying the necessary spectral and 
O2 sensing properties, bio-compatibility, availability and cost. Phosphorescent Pt(II) 
and Pd(II) porphyrins are the most popular, exhibiting lifetimes of approximately 40-
100 μs for the Pt-porphyrins and 400-1000 μs for the Pd-porphyrins displaying 
medium to high O2 quenching. Pt-porphyrins are ideal for O2 measurements from 0-
200 μM i.e. physiological range, while Pd-porphyrins are more useful only in the 
lower <50 μM O2 range [120]. Some of the more popular dyes include PdTCPP, 
PtTFPP, PtCP and Ru(dpp)3
2+. O2 indicator dyes that emit in the visible range (550 
nm-700 nm) are ideal for biological cell monolayer studies [225].  For studies 
involving tissues and samples with a more complicated structure indicators which are 
excitable and emit in the red and near infrared spectrum (600-900 nm) are preferred, 
such as Pt-benzophorphyrins. PtTFPP would be the favoured dye in high resolution 
microscopy due to its high photo-stability and brightness. Pt-porphoryns are also 
preferred over complexes containing Pd as a result of their shorter emission lifetimes 
allowing for much quicker acquisition times [227]. Dyes based around Ru(II) tend to 
have problems with low sensitivity to the O2, lower brightness compared to 
porphyrins, as well as photo-toxicity issues [229]. They also have much shorter 
lifetimes ranging from 1-5 μs [120]. The phosphorescent quenching principle and 
these phosphorescent dyes measure O2 in two main formats, either as an O2 sensing 
probe or as a solid state O2 sensor. 
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Solid state O2 sensors involve the reliable, accurate measurement of extracellular O2, 
or O2 concentration in specific regions of liquid or air. Solid state sensors are used 
primarily in O2 micro-sensors [230], sensor coatings [231] and integrated systems 
[232]. Specific examples include the fibre optic (Micro) sensors, which can measure 
O2 inside tissues using a needle sensor, however they are invasive for cells. The main 
uses of this type of measurement system is the point measurement of O2, OCR and 
scanning of O2 distribution [233]. There are also spot sensors available for point 
measurements of dissolved O2, useful for long term measurements, are non-invasive 
(for pericellular measurements) and display high optical signals [225].  When 
developing solid state sensors, the choice of supporting material is important as it 
affects dye staining and retention, and ensure the dye maintains its photochemical and 
photo-physical properties. Material must also have favourable optical properties and 
be O2 permeable [234].  Different options are available as supporting materials. 
Organic materials such as beads based on poly(styrene-block-vinylpyrrolidone) have 
been used to measure O2, Cl
- and Cu2+ ions [235]. Organic polymers including 
polyethylene, poly(methylmethacrylate),  poly(vinylchloride) and fluoropolymer are 
ideal for O2 imaging as a result of their high permeability and low light absorption 
[234, 236]. Inorganic polymer sensors produced using the sol-gel method can be 
produced with a known composition, have 3D structures ensuring the dye entrapment 
in pores and is easily manipulated by altering pH and temperature in the preparation 
phase. Sol-gel materials however have lower quenching sensitivity and tend to be 
fragile [234]. Hybrid sensing films made up of a mix of organic and inorganic 
polymers [237, 238] ensure resistance to high temperatures, have flexibility, are less 
fragile and allow high gas permeability [239, 240]. Hybrid O2 sensors are categorised 
into two groups, either van der Waals force or covalent bond dependent upon the force 
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between the organic and inorganic molecules [241]. Hybrid films show higher 
sensitivity, faster responses and better linearity of the Stern-Volmer plot compared to 
their uniquely organic or inorganic counterparts [234]. The Stern-Volmer equation 
predicts a linear relationship between the lifetime/intensity values of the probe and O2 
concentration in a heterogeneous microenvironment. However, in many practical 
cases the indicator dye has a heterogeneous micro-environment, leading to non-linear 
Stern-Volmer plots. These  effects can be accounted for using the appropriate 
mathematical or physical model, such as the "two-site" model [226] and the 
corresponding formula: 
Io/I = 1/(f(α1)/(1+ Ksv1[Q]+f(α2)/(1+Ksv2[Q])) 
were fα1 and fα2 are the two fractions, and Ksv1 and Ksv2 their quenching constants 
[242].  
 The second option is the use of soluble probes. These can diffuse across cell 
membranes into respiring cells and tissues measuring intracellular O2. Efficient cell 
loading involves dye modifications through addition of peripheral groups, including 
charged groups or protein binding domains that mediate probe interaction with the 
plasma membrane [243]. They can efficiently stain 3D tissue models, providing a high 
degree of flexibility compared to solid state sensors. However they can have much 
lower signals, and since they are introduced to biological samples must be rigorously 
checked for cell toxicity [225]. Other important parameters to be considered with 
intracellular O2 probes include uniform staining, concentrations and loading times to 
achieve the required optical signals [243]. Distinct categories of probe exist,  including 
small molecule probes, based on derivatives of the PdTPCPP [244], Ru(II) [245] and 
PtCP [246] dyes, with PtTFPP due to its brightness, photostability and price being the 
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most popular. Small molecule probes are produced through functional modifications 
of the dye. They are made up of a hydrophilic dye structure making them highly 
soluble in aqueous media due to the attached carboxylic and sulfonate groups. They 
have their disadvantages however including self-aggregation, hydrophobic cores,  
binding non-specifically to proteins and cell surfaces because of their hydrophobic 
regions and vary in their cell localisation [120]. Another group, micro and nanoparticle 
(NP) based probes involve the covalent or non-covalent incorporation of a dye inside 
a polymer shell, shielding from unwanted molecular interactions and interference from 
the local environment. They are usually larger in size due to their polymeric nature. 
Nanoparticle probes show greater flexibility with the indicator dyes modified to ensure 
the addition of functional groups or by pairing dyes for ratiometric and FRET based 
O2 measurements [247, 248].  The uptake of NPs into cells is believed to be by 
electrostatic interactions with the plasma membrane (negatively charged) and specific 
transport mechanisms such as clathrin mediated endocytosis. Cell staining tends to be 
slower (12-48 h) than for small molecule probes and may not be possible for some cell 
types [243].  
Useful examples of NPs include a probe referred to as NanO2 involving nanoparticle 
formation by combining the cathionic polymer Eudragit RL-100, (a polymer originally 
developed for biocompatible coatings and drug delivery systems) [249] and the 
hydrophobic phosphorescent dye Pt(II)-tetrakis(pentafluorophenyl)porphyrin 
(PtTFPP) [250]. The positive charge on the RL-100 increased the ability of the probe 
to interact with the cell membrane, increasing penetration ability into cells, finally 
localising to the endosomes and lysosomes. There are however issues with neural cell 
staining using these RL-100 based probes. It displays sensitivity to O2 in the 
physiological range [251] with no issues with probe aggregation. It formed a smooth 
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spherical shape with a size of approximately 40nm, capable of efficient staining 
monolayer cells, with no significant cell leakage or toxicity effects. Efficient staining 
was also seen in other cell lines including HeLa, HepG2 and PC12 cell. Due to its 
small size and the high brightness it possesses the probe need only be added at low 
concentrations [250]. Over all it was observed that these probes based on PtTFPP in 
the Eudragit RL-100 polymer are easy to produce, have self-loading ability, high and 
stable phosphorescent signals. They allow for the accurate measurement of cellular O2 
in live cells, and by extension acts as an indicator of cellular responses to drugs, 
metabolic processes, cellular function and viability [250].   
Further developments include the formation of anionic cell permeable phosphorescent 
nanoparticles. The probes are negatively charged poly(methyl methacrylate-co-
methacrylic acid)-based nanoparticles impregnated with the phosphorescent dye 
PtTFPP dye, coupled with a reference dye PFO, known as PA2.  Entering the cell via 
endocytosis  it has been shown to effectively stain primary neurons, astrocytes, PC12 
cells, multi cellular aggregates and the more complex rat brain slices [252]. These 
probes were produced via nanoprecipitation technique [251]. They showed similar 
spectral characteristics to the NanO2 probe, with lifetimes of 31-70 μs in the 0-200 
μM range of O2 but improved staining in different neuronal cell lines. However, it 
showed less efficient staining of fibroblasts. They displayed good  photo-stability, 
lower aggregation and non-specific adsorption [253]. Like cationic probes they 
localised to the endosomes and lysosomes, but also showed improved distribution 
across 3D models including tissue explants. Although these probes were useful in 
numerous cell based studies they had negative issues regarding low staining depths 
for imaging [243]. 
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Conjugated polymer nanoparticles are now the next phase in improving results 
obtained using high resolution O2 imaging, comprised of a conjugated polymer matrix, 
a light harvesting antenna, and a reference all copolymerised with the indicator O2 
sensitive dye. They are also grafted with charged groups capable of ensuring cell 
penetration and stability, allowing for the measurement of both phosphorescent 
lifetime and ratiometric intensity in the visible or near infra-red spectral ranges. These 
probes have improved performance, depth penetration, cell staining and brightness 
when compared to its predecessors [136]. The polymers are comprised of a 
polyfluorene/ poly(fluorene-alt-benzothiadiazole) backbone antenna, both a red as 
well as an infrared emitting reporter based on a Pt(II)-porphyrin and finally various 
charged groups. Variation in the charged groups defines whether the probe is, 
negative, positive or zwitterionic increasing their ability to efficiently stain more 2D 
and 3D models. The zwitterionic probes in particular display more, efficient 
intracellular staining and deeper penetration within samples [136]. As the calibration 
curves for the fluorescent molecular probes become more reliable in cells and tissues 
fluorescence lifetime imaging will become more prevalent and more widely used for 
the investigation of diverse cellular and pathological processes in the future.  
 
1.5 Importance of O2 imaging in cells and tissues 
1.5.1 Effect of hypoxia on cells and tissues physiology  
There is no universal O2 concentration that can be labelled hypoxia, as tissues and 
specific cells experience differences in O2. Thus, hypoxia, can be defined as a 
reduction in O2 tension below that normally experienced by a tissue or a cell. The only 
cell type that experiences close to ambient O2 is respiratory epithelia, while the O2 
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levels in other cell types depends upon distance from the medium or capillary and the 
O2 tension within the capillary where it connects to the cell. Cell responses depend 
upon O2 concentrations and thus experiments carried out using in vitro cells should be 
carried out at physiologically relevant O2 tensions [254]. This too may be left up to 
individual interpretation, for example colon tissues and tumours in vivo have a highly 
heterogeneous O2 concentration ranging anywhere from 0-5 % [255, 256].  
Many O2 probes can be multiplexed with other biomarkers, measuring pH, 
temperature and Ca2+. The ability to ensure O2 homeostasis is pivotal to the survival 
of both vertebrates and invertebrates. Cells in the human body can sense changes in 
O2 availability and can adapt through cellular responses to such stimuli. Adaption 
usually involves alterations in gene expression in response to hypoxia, including 
stabilising of HIF-1α, which in turn activates a great many genes including VEGF 
transcription a regulator of angiogenesis and endothelial cell migration to hypoxic 
areas, as well as GLUT1 and GLUT3 responsible for glucose uptake [257] and EPO 
[258] which is involved in controlling red blood cell production, to name a few. The 
hypoxia inducible factor (HIF) family members are transcription factors that mediate 
the intracellular hypoxic response, inducing gene transcription of genes involved in 
functions like glycolysis, cell proliferation and iron metabolism. HIF is a heterodimer, 
comprised of an O2-regulated α subunit, further divided into HIF-1α, HIF-2α and HIF-
3α isoforms and a constitutively expressed β subunit. Dimerization between both of 
them is necessary for DNA binding [259]. HIF-3α lacks the C-terminal activation 
domain needed for co-activator binding, thus it is unable to recruit co-transcriptional 
regulators and basal transcription machinery to gene targets [260]. Under normoxic 
conditions HIF-1α binds Von Hippel-Lindau (VHL) protein, which recruits a ubiquitin 
ligase that ensures HIF-1α is degraded in the proteasome. It is the role of prolyl 
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hydroxylases (PHDs), specifically PHD2 that mediate HIF-1α hydroxylation, via VHL 
binding to the HIF-1α proline residue using O2 as a substrate. As a result its binding 
is inhibited in hypoxic conditions [261]. In hypoxia HIF-1α and HIF-2α hydroxylation 
is decreased, resulting in HIF-α stabilisation/accumulation and increasing 
transcriptional activity of genes involved in cell survival, proliferation and energy 
metabolism as well as apoptosis and autophagy. In acute hypoxia, HIF-1α is associated 
with cell death, while in solid tumours it aids cell survival and proliferation. The 
switch from pro survival to pro-apoptotic pathways is not well understood but may be 
because of binding to proteins such as p53. There is also a feedback loop  and induces 
the transcription of PHDs, ensuring that after prolonged hypoxia HIF returns to low 
undetectable levels [262]. These PHDs particularly PHD2 may have a major role in 
controlling HIF dynamics preventing cell death by increased HIF-1α levels. It was 
noted that in HeLa cells lacking PHD2 expression, p53 was shown to sustain high 
levels, suggesting apoptosis was occurring [262]. 
There are also several HIF-independent pathways that are equally as important for a 
cells response to hypoxia, via some major signalling pathways. The mammalian target 
of rapamycin (mTOR) complex 1 pathway, which phosphorylates S6 kinase and 4E-
BP is inhibited. This leads to the inhibition of ribosomal biogenesis and cap-dependent 
translation and by extension protein translation, saving energy under sever hypoxia. 
When cells are exposed to ER stress and unfolded proteins accumulate in the ER, cells 
activate the unfolded protein response (UPR) to maintain protein quality or induce cell 
death. UPR is activated in hypoxia by PERK, IREL andATF6. PERK inhibits 
translation of proteins via eIF2 phosphorylation, while IRE1 increases apoptosis.  The 
nuclear factor-kappa B (NF-κB) pathway, is a key transcription factor in immune 
response but also plays a major role in hypoxia response. The NF-κB pathway is 
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activated under hypoxia, inducing HIF-1α mRNA, while also being induced by HIF-
1α aiding cell survival.  When activated in tumours it aids in tumour angiogenesis. 
The downregulation of PHD2 increases NF-κB activity and upregulates IL-8 and 
angiogenin gene expression [263]. 
Hypoxia within tumours and disease tissue results from inadequate perfusion and 
reduced O2 transport [264]. Hypoxia in tumours can cause resistance to radiotherapy, 
with a decrease in sensitivity noted when O2 levels drop below 2.6 %. Furthermore it 
may lead to malignant progression, as tumour cells that can withstand hypoxic 
conditions increase the number of clonogens that increase tumour size and produce 
metastatic cells [265]. Cancers also have greater rates of cell proliferation and a lack 
of vasculature leading to areas of hypoxia. Increased HIF-1α and HIF-2α levels as a 
result of stabilisation are observed in biopsies and boost mortality rates in bladder, 
brain, breast and colon cancers while a loss of HIF-1α expression can decrease tumour 
growth [266]. HIFs activate gene transcription involved in cell immortalization, 
epithelial-mesenchymal transition [261], vascularisation [267], pH regulation [268], 
invasion and metastasis [269], and radiation resistance [270].  As a result of hypoxic 
microenvironments in diseased tissue an increase in HIF-1α has been observed, 
indicating it may be a possible therapeutic target [271]. Diseases involving the lung 
can often lead to hypoxia and by extension result in pulmonary hypertension. This 
exposure to hypoxia can lead to increased proliferation of smooth muscle in the 
pulmonary artery, with HIF-1α playing a pivotal role in the development of this 
hypertension [272]. Hypoxia caused by sleep apnea leading to lower O2 in the blood 
affects the pharyngeal soft tissue. Alternating between hypoxic and re-oxygenated 
states within the tissue causes increased ROS levels in the brain. Hypertension is 
caused as a result of increased plasma catecholamine levels [273]. Moreover, hypoxia 
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leads to impairment of mitochondrial respiration, inhibition the respiratory chain and 
increased proton leaking. To adapt to hypoxia cells and tissues  must increase the 
efficiency of energy production pathways, primarily by increasing anaerobic 
glycolysis activity as well as decreasing energy-consumption processes [274]. This 
switch from oxidative metabolism to anaerobic glycolysis, increasing glucose uptake 
and utilisation is a phenomenon known as “the Warburg effect”. Only in anaerobic 
conditions will normal cells produce large amounts of lactate, however cancer cells 
produce large amounts of lactate regardless of oxygen concentration, due to its desire 
to produce energy via glycolysis, known as “aerobic glycolysis”. This form of energy 
production is sufficient for cell proliferation, however it is an inefficient method for 
adenosine 5’-triphosphate (ATP) generation, thus the reason for the switch occurring 
in cancer cells is unclear [275]. This increase in glucose uptake is seen in adipocytes 
and can lead to increased lactate production, hypoxia induced insulin resistance in fat 
cells and thus development of fibrosis in adipose tissue. Hypoxia is therefore linked 
to defects in the appropriate function, obesity and obesity related diseases [276].  
This ability of cells to successfully adapt to hypoxia was observed in another unrelated 
study using glioblastoma (aggressive brain tumour) cells. Results showed that in O2 
levels of 1-8% there was no effect on cell cycle. Cell cycle arrest and minor cell death 
were only seen when cells were exposed to 0.1 % O2 [277]. The large number of 
disease states associated with hypoxia and its links to malignancy, invasiveness and 
resistance to chemotherapeutic treatment make O2 probes and accurate measuring of 
intracellular O2 in 3D models of utmost importance.  
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1.6 Summary  
While advancements have been made in 3D it is important to remember their relevance 
is only important should they be capable of accurately mimicking in vivo conditions. 
This is only possible by optimising the conditions and monitoring the gradients in 
molecules such as O2, Ca
2+ and NADPH as well as monitoring gradients in pH and 
temperature. By building up our knowledge of these conditions we can have a greater 
understanding of what is required and what must be altered to make these models more 
physiologically relevant. This work in model development will be aided through better 
knowledge of natural tissues using fluorescent probes and markers, which in turn can 
then be used in further studies. The complexity of both the models and the probes are 
always changing, always improving, ensuring great leaps in cellular pathway and gene 
expression studies as well as drug evaluation studies. 
 
1.7 Thesis aims  
The overall aim of this thesis was to develop new sensors, probes and protocols for 
oxygen imaging in 3D cell cultures. Specifically, we wished to develop a new 
improved O2 sensitive solid state sensor, capable of non-invasively measuring peri 
cellular and extracellular O2. Furthermore, we wanted to evaluate new O2 and 
Temperature based water soluble intracellular nanoparticle probes, all of which are 
covered in chapter 3. In chapter 4 we look at some of the possible applications of our 
new sensors and probes. We optimised the 3D spheroid model and incorporating the 
resulting in vitro tissues into our research. Interesting applications included our 
metabolic study, imaging simultaneously O2 and T dynamics in 3D spheroids, drug 
toxicity studied using the chemotherapeutic drug tirapazamine and a mechanistic study 
investigating the role of SPCA2, the Ca2+/Mn2+ pump in hypoxia, in both monolayer 
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and 3D cultures. In summary, we wished to highlight the importance of measuring 
both O2 and temperature in all areas of research, emphasising the effects these 
metabolic parameters have on cell viability, gene expression and drug efficacy.  
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Chapter 2. Materials and Methods 
2.1 Materials  
PtTFPP dye (Cat # PtT975) was from Frontier Scientific (Inochem Ltd, Lancashire, 
UK). ProLong Gold anti-fade reagent, Tethramethylrhodamine, methyl ester 
(TMRM), CellEvent Caspase-3/7 substrate, Cholera Toxin sub-unit B, MitoTracker 
Green and LysoTracker Red were from Invitrogen (Biosciences, Dublin Ireland). 
CellTox Green assay kit and CellTiter-Glo kit were from Promega (MyBio, Ireland). 
ROSstar 550 dye was from Li-Cor (USA). MitoImage-NanO2 phosphorescent O2 
probe [278] and pH-XtraTM [279] were from Luxcel Biosciences (Cork, Ireland). SII-
0.2+ copolymer nanoparticles were prepared as described before [136]. Perylene 
bisimide-based pH probe NSP was prepared as described before [280]. Bis-Benzimide 
Hoechst 33342 and Calcein Green AM probe were from Sigma-Aldrich (Dublin, 
Ireland). Mouse monoclonal anti-BrdU ‘BU-1’ antibody (Cat # 05-633) and mouse 
monoclonal anti-SERCA2 antibody (Cat # MAB2636) were from Millipore (Cork, 
Ireland). Mouse monoclonal anti-HIF1α antibody (Cat # MAB1536) was from R&D 
systems (Oxfordshire, UK).  Rabbit polyclonal anti-Tyrosine Hydroxylase antibody 
(Cat # ab41528) was from Abcam (Cambridge UK). Mouse monoclonal anti-α-
Tubulin antibody (Cat # T5168), HRP (horseradish peroxidase)-conjugated secondary 
mouse anti-rabbit (Cat # A1949) and goat anti-mouse (Cat # A9917) were from Sigma-
Aldrich (Dublin, Ireland). Alexa Fluor-488 goat anti-rabbit (Cat # A11034), Alexa 
Fluor-488 goat anti-mouse (Cat # A10680) and Alexa Fluor-594 goat anti-mouse (Cat 
# A11032) conjugated secondary antibodies were from Invitrogen (Biosciences, 
Dublin Ireland). Epidermal growth factor (EGF) and fibroblast growth factor (FGF) 
were from Promega (MyBio, Ireland). B27 serum-free supplement was from 
60 
 
Invitrogen (Biosciences, Dublin Ireland). Cantharidin, FCCP, oligomycin, 
Tirapazamine, MnCl2, BrdU, oligonucleotides and all the other chemicals (HPLC or 
spectrophotometric grade) were from Sigma-Aldrich (Dublin, Ireland). Polystyrene 
scaffold membranes AlvetexTM (12-well inserts) and LipidureTM plates were from 
Amsbio (UK). Perfecta 3D Hanging drop plates were from 3D Biomatrix (UK). Ibidi 
µ-slide 8/12-well chambers were from Ibidi (Martinsried, Germany). TransIt-X2 
reagent was from Mirus (MyBio, Dublin, Ireland). PCR master mix, Improm-II 
reverse transcriptase, ribonuclease inhibitor and ReliaPrep total RNA extraction kit 
were from Promega (MyBio, Ireland). qPCR reagent and Nucleo-spin II Total RNA 
extraction kit was from Macherey-Nagel (Thermo Fisher scientific, Dublin, Ireland). 
ECL Prime chemiluminescent substrate was from GE Healthcare (Cork, Ireland). The 
sterile plasticware (cell culture grade) was from Sarstedt (Wexford, Ireland). GPP130-
GFP plasmid DNA was kindly provided by from Prof. A. Linstedt and Dr. S. 
Mukhopadhyay (Carnegie Mellon University, Pittsburgh, USA). Plasmid DNAs 
encoding hSPCA2 and hSERCA2b and anti-SPCA2 polyclonal rabbit antibody were 
provided by Prof. F. Wuytack and S. Smaardijk (Laboratory of Cellular transport 
systems, KU Leuven, Belgium). Plasmid DNAs for transfection were purified from 
E.coli using Genopure Plasmid Midi Kit (Roche). Rabbit polyclonal pan-SPCA 
antibody [281] was provided by Dr. N. Pestov (Shemyakin-Ovchinnikov Institute of 
Bioorganic Chemistry, Russia). Mouse colon RNA samples isolated from normal and 
hypoxia-preconditioned mice [282] were provided by Dr. I. Okkelman, Dr. A. 
Zhdanov and Prof. K. O’Halloran (University College Cork, Ireland). 
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2.2 Cell culture 
Human colon carcinoma HCT116 cells and rat pheochromocytoma PC12 were 
obtained from ATCC (Manassas, VA, USA). Knock out HCT116 (SCO2-/-) cells were 
provided by Prof. P. M. Hwang (NIH, Bethesda, MD, USA). Human colorectal 
carcinoma HCT116 cells WT (wild type) and SCO2-/- were grown in McCoy 5A 
medium supplemented with (10 % v/v) fetal bovine serum (FBS, heat-inactivated), 10 
mM HEPES, pH 7.2, 2 mM Glutamine and penicillin-streptomycin (1 % v/v) in cell+ 
flasks (cell plus, yellow capped, adhesion flasks). Prior to seeding in scaffolds PC12 
cells were grown in RPMI-1640 media with (10 % v/v) horse serum (HS), (5 % v/v) 
fetal bovine serum (FBS, heat-inactivated), 10 mM HEPES and penicillin-
streptomycin (1 % v/v). 
For O2 and T probe calibrations and immuno-staining cells were seeded on collagen 
IV: poly-D-lysine (0.07 mg/ml: 0.03 mg/ml) pre-coated 35 mm glass bottom dishes 
(MatTek) or multi-well micro-chambers (Ibidi). For analysis of effects on cell 
viability, HCT116 cells were seeded on 96-well flat bottom micro-plates, pre-coated 
with mixture of 0.1 mg/ml collagen IV and grown until forming a monolayer.  
Staining with LysoTracker Red (100 nM), MitoTracker Green (50 nM), Calcein Green 
AM (1 μM), CellTox Green (0.1 % v/v), Cholera toxin (2.5 ng/ml), Hoechst 33342 (1 
µM) and TMRM (20 nM) was performed by incubating with cells/spheroids for 30 
min and one wash step. Prior to imaging, cells were equilibrated in Phenol Red-free 
DMEM medium supplemented with 10 mM glucose, 1 mM pyruvate, 2 mM 
glutamine, 10 mM HEPES, pH 7.2. Spheroids were allowed attach for (3-8 h) on 
collagen IV: poly-D-lysine (7: 3 ratio) pre-coated glassware. 
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2.3 Preparation of O2-sensitive 3D scaffolds 
PtTFPP dye was dissolved at 0.025-0.05 mg/ml in acetone: water (7: 3) mixture at 
room temperature, and 1 ml aliquots of this solution were added to the AlvetexTM 
scaffold membranes placed individually in wells of a standard 24-well polystyrene 
plate. The soaked membranes were incubated for 1 h at 60 oC, then washed 
sequentially (each time 5 min at 60 oC) with 1 ml of acetone: water (3.5:6.5), acetone: 
water (1.5: 8.5) and lastly with sterile water. The stained "O2-scaffolds" were dried 
under sterile laminar air flow and stored at room temperature protected from light and 
contamination. 
 
2.4 Growth and treatment of cells in the O2 scaffolds 
Prior to cell seeding, dried O2 scaffolds were pre-soaked in small amount of 70% 
ethanol and then rinsed three times with 1 ml of sterile PBS. After seeding, cells were 
allowed grow inside the scaffold for 1-5 days.  
Rat pheochromocytoma PC12 cells were cultured in Phenol Red free DMEM (Sigma 
D5030) supplemented with 10 mM glucose, 1 mM pyruvate, 2 mM l-glutamine, 10 
mM HEPES, (1 % v/v) Penicillin-Streptomycin, (2 % v/v) B27, 20 ng/ml EGF, 10 
ng/ml FGF and 100 ng/ml NGF to produce suspension cells and multi-cellular 
aggregates following 3 days culturing [283] and then seeded at a density of 60-100 
aggregates per O2 scaffold. Cell viability was assessed by analysing membrane 
integrity using the CellTox Green assay (0.1 % v/v, 30 min) and number of viable cells 
stained with TMRM (20 nM, 30 min) in comparison with control unstained scaffold. 
In preparation for drug treatment O2 scaffolds were seeded with 60-100 PC12 
aggregates per scaffold in serum free media (SFM) and grown for 3 days. 1 mM TPZ 
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(or 1 % v/v, DMSO in controls) was added simultaneously with (0.1 % v/v) CellTox 
green and TMRM (20 nM) to the membranes and incubated for 40 minutes. The 
membranes were washed once with 1 ml of Phenol Red free DMEM media containing 
TMRM. The numbers of dead cells and corresponding phosphorescence lifetimes 
were then determined and compared to the control samples.  
 
2.5 Measurement of PtTFPP dye leaching using micro-plate reader  
Dye leaching experiments were carried out on a high-sensitivity time-resolved 
fluorescence (TR-F) reader Victor2 (PerkinElmer). Supernatants from samples with 
O2 scaffolds were taken periodically and measured 5 times over 10 min in the wells of 
96well micro-plate under the following settings: mode - time-resolved fluorescence; 
filters - D340 excitation and D642 emission, delay time – 30 μs, gate time – 100 μs, 
cycle time – 1000 μs. Mean signal values were then calculated.  
 
2.6 DNA transfection and hypoxia treatment of adherent cell culture   
HCT116 cells [284] were washed with PBS, trypsinised and split 1:10 every 2-3 days 
when not being seeded for experimentation [285]. Typically, cells were grown in 
McCoy 5A medium supplemented with (10 % v/v) fetal bovine serum (FBS, heat-
inactivated), 10 mM HEPES, pH 7.2, 2 mM Glutamine, penicillin-streptomycin (1% 
v/v) in cell+ (cell plus, yellow capped, adhesion flasks) flasks. Control and hypoxia 
(continuously exposed at 3% O2, in an airtight incubator with attached heating and O2 
controls for 7 days, including cell passaging and seeding) – treated cells were normally 
harvested at 50-70% of confluence unless indicated otherwise. DNA transfection of 
adherent cells was performed using TransIt-X2 reagent (Mirus), as per manufacturer’s 
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instructions. Briefly, cells seeded at 70-75% confluence were transfected with 
GPP130-GFP, hSPCA2 and hSERCA2b-encoding plasmid DNAs in Opti-MEM I 
medium for 24-36 h and then analysed. For the treatment with MnCl2, cells were first 
transfected for 18 h and then exposed to 0.5 mM MnCl2 for 24 h. For 
immunofluorescence cells were pre-stained with BrdU (100 µM, 30 min). 
 
2.7 RNA extraction and PCR analysis  
2-4*106 cells were washed with PBS and total RNA was immediately isolated using 
Nucleo-spin II RNA extraction kit (Macherey-Nagel), per manufacturer's instructions. 
For spheroid cultures, RNA was extracted from pooled spheroids (72 for 1,000 or 24 
for 3,000 initially seeded cells) using the ‘ReliaPrep’ extraction kit (Promega, MyBio, 
Ireland) accordingly to manufacturer’s instructions. 1-2 µg of total RNA annealed with 
500 ng oligo-(dT)15 (70 
oC, 5 min, then 4 oC, 5 min), reverse transcribed using 
ImProm-II Reverse transcriptase (42 oC, 2 h), heat-inactivated (70 oC, 15 min) and 
stored at -18 oC. cDNA was used for semi-quantitative PCR analysis (25-35 cycles) 
or real-time PCR using qPCR reagent (Maxima SYBR green, Fisher Scientific), and 
the AB7300 Real-Time PCR machine, analysed using the 7300 system SDS software 
from Applied Bio-systems (Life technologies) (45 cycles). The sequences of 
oligonucleotides are presented in (Tab. 2.7).   
 
 
 
 
 
 
65 
 
Table 2.7 Sequences of oligonucleotide primers used in the study. 
Name/ Gene ID, Acc. Number Sequence (forward, reverse) 
B-actin (Human), ACTB F 5' CCACCATGTACCCTGGCATT 
R 5' CGGACTCGTCATACTCCTGC 
B-actin (Mouse), ACTB F 5' TGGCTCCTAGCACCATGAAG 
R 5' ACGCAGCTCAGTAACAGTCC 
MIST1 (human), BHLHA15  F 5' CTCACGCTGGCCAAGAACTA 
R 5' GTGGATCTGCGTGGAGTACC 
PMCA1 (Human), ATP2B1, 
NM_001001323 
F 5' GGATACACTCGCTTCCCTGG 
R 5' AGGAGCATGCAAAGGAGCAT 
PMCA2 (Human), ATP2B2, 
NM_001001331 
F 5' GGCGACAATATCAACACGGC 
R 5' AGGGTATGCTTGTCCGTTGG 
PMCA3 (human), ATP2B3, 
NM_001001344 
F 5’ CCGTGGTCCAGTCCTACCTA 
R 5’ TTCAGGTCCAAGACGAAGCC 
PMCA4 (human), ATP2B4, 
NM_001001396 
F: 5’ CCTGTGGCTGAGATTGTGGT 
R: 5’ GGCCAGAACCTTCCATGACA 
SERCA2ab (Human), ATP2A2, 
NM_170665 
F 5' GGAGAGAACACCCCTTCAGC 
R 5' GACCTTCAGGAATGGCTGCT 
SERCA3a (Human), ATP2A3, 
NM_005173 
F 5' CTGGATGAACCCCTGGCTG 
R 5' ATGTGGTTCCGGGACAGGTA 
SPCA1 (Human), ATP2C1, 
NM_001199179 
F 5' AGATTCCAGCTGAGCACGAG 
R 5' CTTTCCAGTTGCGAGGAGGT 
SPCA2 (Human), ATP2C2, AY791884 F 5' ACTTACACACTGGGCTGTCG 
R 5' CTGACGGCGTCCTCATACTC 
SPCA2 (Mouse), ATP2C2, 
NM_026922 
F 5' CCAGAGTGCAACTGCCTGAG 
R 5' CCAGTGGGCTGTCTGTTTTG 
 
2.8 Production and analysis of spheroids   
Three different methods of spheroid production were used: (1) in "free floating" (FF) 
method cells were seeded at concentration 5*106 cells in 5 ml of Serum-free medium, 
SFM (Phenol Red-free DMEM, 10 mM Glucose, 1 mM sodium pyruvate, 2 mM 
Glutamine, 10 mM HEPES-Na, pH 7.2, (1% v/v) Penicillin-Streptomycin, 1x B27, 20 
ng/ml EGF and 10 ng/ml FGF in 25 cm2 low adhesion flask [286]. Spheroids were 
formed after 3 days of culture. (2) ‘Hanging drop’ method used seeding of cells at 
various concentrations in 40 µl of McCoys 5A medium supplemented with (10% v/v) 
fetal bovine serum (FBS, heat-inactivated), 10 mM HEPES, 2 mM Glutamine, (1 % 
v/v) penicillin-streptomycin per well, followed by addition of PBS to the 96-well plate 
to prevent the excessive evaporation [287]. Lipidure® method used seeding of various 
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concentrations of cells in 200 µl growth medium and 3-day incubation in 96-well 
round-bottom hydrophobic microplates (Lipidure-coat, Amsbio, UK), spheroids of 
approx. 400-650 µm size were formed after the 3 days (3).  
 
Spheroid staining with SII-0.2+ (5 µg/ml), NanO2 (5 µg/ml), pH (5 µg/ml), ROSstar 
(5 µM) and CellTox Green (0.2 % v/v) was performed by addition of the probe to 
growth media at the start of spheroid formation and incubation for 3 days i.e. 
"continuous staining" procedure. Staining with T probe (1 ug/ml) was performed by 
adding to media 17h prior to imaging to already formed spheroids i.e. post formation 
staining procedure. Staining with TMRM (20 nM, 30 min) was achieved with pre-
formed spheroids. To label proliferating cells, BrdU (200 µM) was added to pre-
formed spheroids 16-18 h before the fixation. For microscopy, spheroids were re-
seeded and allowed to attach (3-8 h) on MatTek 35 mm glass-bottom dishes (MatTek) 
pre-coated with mixture of Collagen IV and poly-D-lysine (7:3 ratio respectively) 
[278]. Live spheroids were routinely, washed twice prior to imaging, which was then 
performed in phenol red-free DMEM supplemented with 10 mM glucose, 1 mM 
sodium pyruvate, 2 mM L-glutamine and 10 mM HEPES-Na, pH 7.2 at 37 oC and 
ambient O2 (21 %). 
 
2.9 Protein extraction and western blotting  
2-4*106 cells were washed with PBS and lysed in RIPA buffer (25 mM Tris-HCl pH 
7.6, 150 mM NaCl, 1% v/v NP-40, 1 % sodium deoxycholate, 0.1 % w/v SDS) 
supplemented with PhosSTOP phosphatase inhibitors (Roche 4906837001) and 
protease inhibitor cocktail (Sigma P2714) for 10-15 min on ice with gentle rocking. 
Extracts were cleared by centrifugation (15,000 g, 15 min, 4 oC) and total protein was 
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quantified by the BCA protein assay kit (Pierce). Samples normalised for total protein 
were mixed with 5X Sample Laemmli Buffer (4 % w/v SDS, 20 % v/v glycerol, 10 % 
v/v 2-mercaptoethanol, 0.004 % w/v bromphenol blue and 0.125 M Tris HCl, pH 6.8), 
incubated for 10 min at room temperature (no boiling, preventing any protein 
degradation). Proteins were separated by 8 % polyacrylamide gel electrophoresis 
(GenScript, NJ) in 1X running buffer (Tris base 3.03g, glycine 24g, SDS 1g, dissolved 
in 1000ml deionised water). The gel was transferred (slide the gel manually) onto a 
0.2 µm ImmobilonTM-P PVDF membrane (Sigma). This was placed into a transfer 
chamber with the proteins passing from the gel into the PVDF membrane as the 
transfer buffer (Tris base 3.03g, glycine 14.4g, methanol 200ml, dissolved in 800ml 
deionised water) runs from the cathode (-) towards the anode (+). The membrane was 
then probed with antibodies. Incubations with antibodies were performed in (5% w/v) 
fat-free milk/TBST overnight at 4 oC (primary) and 1-2 h room temperature 
(secondary). Immunoblots were analysed using HRP-conjugated secondary antibodies 
(Sigma) and AmershamTM ECLTM Prime reagents with the LAS-3000 Imager 
(Fujifilm, Japan) and Image Reader LAS-3000 2.2 software. 
 
2.10 ATP and ECAR measurements  
Total cellular ATP was measured [288], using CellTiter-Glo reagent (Promega). 
Briefly, spheroids were allowed attach to the collagen-coated 96-well plates in Phenol 
Red-free DMEM for 3 h, at concentrations approx. 1 spheroid of 6,000 cells/ per well 
(Lipidure or "hanging drop" methods), approx. 12-18 spheroids/ per well ("free 
floating" method) or 30,000 cells per well for mono-layered cells. After attachment, 
equal amount of CellTiter-Glo reagent was added, lysates were mixed via intensive 
shaking and transferred to white 96-well plates (Greiner Bio One). The luminescence 
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was analysed on time-resolved fluorescence plate reader Victor2 (Perkin Elmer). 
(ECAR) was measured [289] with the pH-XtraTM probe (Luxcel Biosciences). Briefly, 
cells grown on microplates were treated with various concentrations of T (0-2 µg/ml) 
and SII-0.2+ (0-20 µg/ml) for 16 h, washed and measured using Victor2 time-resolved 
fluorescence plate reader (Perkin Elmer). ECAR values were normalized by total 
protein content, measured using BCA method. 
 
2.11 Immunofluorescence  
For immunofluorescence, cells grown in O2 scaffolds were fixed in paraformaldehyde 
(4 % w/v, 10 min, RT). Fixed cells in O2 scaffolds were permeabilised with 0.25% v/v 
Triton X-100, then blocked with 5% v/v, bovine serum in TBST and immunostained 
with anti-tyrosine hydroxylase antibody (Abcam, ab112) in TBST (16 h, 4 ˚C). 
Washed with TBST (1 h, 5 times), incubated with appropriate Alexa Fluor-conjugated 
secondary antibodies 1:1000 dilution (2 h, RT), washed with TBST (1 h, 5 times). 
Spheroids were fixed in paraformaldehyde solution (4 % w/v, 40 min, RT), washed 
with PBS (0.5 h, 5 times), blocked in 10% fetal bovine serum (FBS) supplemented 
with 0.4 % v/v Triton X100 in PBS (2 h, room temperature), incubated with primary 
antibodies in 2.5 % v/v HS, 0.4 % v/v Triton X100 in PBS (48 h, 4 ˚C), washed with 
TBST (1 h, 5 times), incubated with appropriate Alexa Fluor-conjugated secondary 
antibodies 1:1000 dilution (18 h, 4 ˚C), washed with TBST (1 h, 5 times), counter-
stained with DAPI (14 μM, 1 h). Samples were then mounted between coverslips in 
ProLong Gold antifade medium (Invitrogen) and subjected to fluorescence 
microscopy analysis. 
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Immunostaining with monolayer cells were performed as with the above O2 scaffolds 
[73] using cells grown on 12 well µ-slide (Ibidi) and probed with rabbit antibodies 
against cleaved Caspase-3 (Cell Signalling), rabbit anti-SPCA2 (XIB, provided by 
Prof. F. Wuytack), mouse anti-SERCA2 (Millipore) or BU-1 (Millipore) antibodies, 
followed up by staining with Alexa Fluor 488 or 594-labeled secondary antibodies 
(Invitrogen) and staining of nuclei by DAPI (300 nM, 5 min). Samples were analysed 
by widefield fluorescence microscopy.  
 
2.12 Widefield PLIM microscopy 
The live cells, transfected with GPP130-GFP plasmid DNA [290] and counter-stained 
with LysoTracker Red (0.1 µM, 30 min), as well as fixed and immunostained cells, 
O2 calibrations and photobleaching experiments were performed on a wide-field 
inverted microscope Axiovert 200 (Carl Zeiss) equipped with an oil-immersion 
objective 40×/1.3 EC Plan Neofluar and 100x/1.4 Plan Apochromat, 470 and 590 nm 
LED excitation module, time-gated CCD camera and emission filters DAPI (Semrock 
5060B-ZHE), FITC (472/30 nm ex., 535/55 nm em.) and TXRed (Semrock 4040B-
ZHE) 390, 470 and 590 nm LED excitation module, ImSpector software (LaVision 
BioTec, Germany) and integrated CO2/O2 climate control chamber (PeCon) [278]. In 
PLIM mode the parameters were: snapshot mode, 50 ms exposure, devices delay T. 
For the intensity imaging the parameters were: exposure time - 2 ms, devices – none, 
DC mode – ON, no binning. Photobleaching experiments were performed in DC mode 
with the following settings: exposure time - 2 ms, devices - time-time, numbers of 
steps - 12, wait time - 10 s. 
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2.13 Confocal FLIM-PLIM microscopy  
Analysis of cell staining, 3D O2 scaffolds, spheroid culture, T calibrations and multi-
parametric measurements were performed on an TCSPC one-photon laser-scanning 
upright Axio Examiner Z1 microscope (Carl Zeiss), equipped with 20×/1.0 W-Plan-
Apochromat and 63x/1.0 W-Apochromat objectives, temperature control (external 
incubator and heated stage, 25 oC-42 oC) with motorized Z-axis control, DCS-120 
time-correlated single photon counting confocal scanner (Becker & Hickl GmbH), 
R10467U-40 and R10467U-50 photon counting detectors (Hamamatsu Photonics 
K.K.) and dedicated TCSPC hardware (Becker & Hickl GmbH)[278, 289]. SI-0.2+ 
nanoparticles were excited using picosecond pulsed diode 405 nm laser BDL-SMC 
(Becker and Hickl GmbH) with emission collected at 635-675 nm (O2 dye, PLIM 
mode). SII-0.2+ nanoparticles were excited using supercontinuum tunable laser 
SC400-4 (Fianium, UK) at 620 nm with emission collected at 750-810 nm (O2 dye, 
PLIM mode). The fluorescent and phosphorescent probes were excited using tunable 
picosecond supercontinuum laser SC400-4 (Fianium, UK) at 488 nm (CellTox Green, 
Calcein Green, Alexa Fluor 488Cholera toxin, MitoTracker Green), 540 nm (T probe, 
LysoTracker Red, TMRM) and 620 nm (SII-0.2+). The following emission filters were 
used: 512-536 nm (for 488 nm), 565-605 nm (for 540 nm) and 760-810 nm (for 620 
nm). NanO2 and Hoechst 33342 were excited using BDL-SMC picosecond 405 nm 
laser (Becker & Hickl GmbH) with emission collected at 635-675 nm (NanO2) and 
438-458 nm (Hoechst 33342).  Fluorescence lifetimes for T probe were analyzed using 
SPCM64 and SPCImage software (Becker & Hickl GmbH) using mono-exponential 
decay function (T1=50, T2=150, binning factor=4, threshold=10, shift=0, offset=0). 
For T-dependent calibration, cells were pre-incubated at different temperatures for 10 
min, before measurements of fluorescence lifetimes. The following calibration was 
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produced: T (oC) = 105.6-0.0277*τ, r2=0.99 where τ is in ps. Phosphorescence 
lifetimes of O2 probe (SII-0.2
+) were fitted using mono-exponential decay function 
(T1=120, T2=225-240, binning factor=3, threshold=10, shift=0, offset=0). Processed 
decay times were exported and further combined in Excel, Origin 6.0, Fiji and Adobe 
Illustrator software. The phosphorescence of O2 scaffolds was excited at 534 nm and 
collected with 635-675 nm bandpass filter, and lifetimes were calculated by mono-
exponential fitting of decay curves in SPCImage software (Becker & Hickl GmbH) 
using the following settings: Shift: 0-10, Binning: 1-3, T1: 120-140, T2: 230-250. 
Drug treatments (FCCP, AntA, Tirapazamine) were performed using addition of 10x 
concentrated stocks in Phenol Red free DMEM at 1/10 of total volume with live 
samples. For scaffold 3D reconstruction samples were fixed with PFA, immunostained 
(see 2.11) and scanned in Z direction (20-25 optical sections, 2 μm thickness, 40-50 
μm total depth). The fluorescent probes were excited with tunable picosecond 
supercontinuum laser SC400-4 (Fianium, UK) or BDL-SMC 405 nm pulsed diode 
laser (Becker & Hickl GmbH) for NanO2. O2 imaging with NanO2 probe was 
performed using long pass excitation (>435 nm for laser 405 nm) and bandpass 
emission (655/40 nm for PtTFPP). Lifetimes were translated to O2 values using the 
following calibration function: [O2, μM] = 9274.667*exp(−τ/7.27143), where τ is in 
μs [278]. Alexa Fluor 488, CellEvent Caspase 3/7 and CellTox Green dyes were 
excited at 488 nm with emission collected at 512–536 nm. TMRM was imaged using 
540 nm excitation, 565-605 nm emission; Alexa Fluor 594 was excited at 594 nm, 
with emission collected at 635-675 nm. Transmission light images were collected with 
a D5100 digital SLR camera (Nikon) attached to the microscope.  
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2.14 Data analysis and statistics 
Fitting of phosphorescence decays was performed either in ImSpector software 
(widefield PLIM, La vision) or SPCImage software (Becker & Hickl) using single-
exponential decay function and pixel binning as appropriate. The resulting 2D 
matrices with lifetime data were converted to ASCII format and processed in 
Microsoft Excel to produce O2 concentration values using calibration function. 3D 
projections of O2 scaffolds and 3D projections of spheroids were produced from 
intensity images representing individual optical sections using Volume Viewer plugin 
(Fiji software (http://fiji.sc/Fiji)), cells stained with CellTox Green and other dyes 
were counted using ’3D objects counter’ plugin in Fiji software. Localisation of 
GPP130 to the lysosomes was carried out using the co-localisation threshold plugin in 
Fiji software. Data are presented as average values with standard deviation shown as 
error bars.  
Data are shown as average values with standard deviation as error bars. To ensure 
consistency of results, all the experiments were performed in triplicate. For statistical 
significance, data were evaluated using independent t-test, with confidence levels 
P=0.05 and P=0.005, indicated with asterisks in figures. Western blotting, qPCR data 
and localisation experiments were evaluated for statistical differences using t-test with 
confidence levels of P<0.05, 0.005 or 0.001 (marked by an asterisk) accepted as 
significant. Electrophoretic band intensities were quantified in Fiji software and then 
averaged between 3 independent experiments with standard deviations are shown as 
error bars. qPCR experiments were normalised to control β-actin signals and compared 
between 3 independent experiments. 
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Chapter 3. Evaluation of novel photoluminescence based O2 
and temperature probes 
Abstract 
Porous scaffolds are commonly used to produce 3D cell cultures and tissue models. 
The modification of these materials can significantly increase their uses as well as 
operational performance. Here we introduce a novel hybrid microporous polystyrene-
based scaffold impregnated with PtTFPP, a phosphorescent dye sensitive to O2 
concentrations. Our scaffold falls into the category of solid state oxygen sensors. The 
scaffolds are compatible with live cell fluorescence microscopy, possess high 
brightness and stable responses to O2 in phosphorescence intensity and lifetime 
imaging modes. They allow for the better control of conditions in 3D tissue cultures, 
as well as being useful in a broad range of biomaterial and physiological studies. We 
moved on to evaluate our water soluble, intracellular probes, first looking at a novel 
intracellular nanoparticle probe capable of measuring O2. The probe was developed 
specifically for high resolution imaging of O2, consisting of a substituted conjugated 
polymer (poly(fluorene-alt-benzothiadiazole)) which acts as a FRET antenna and a 
fluorescent reference with covalently bound phosphorescent metalloporphyrin 
(PtTPTBPF). These nanoparticles displayed efficient high stability, brightness and 
compatibility with lifetime based imaging modes as well as low toxicity for cells. The 
positive charge on the nanoparticles ensured high cell staining efficiency, proving to 
be a versatile tool for quantitative O2 imaging in HCT116 cells. Finally, we evaluate 
a new cell-permeable temperature sensitive fluorescence lifetime-based nanoprobe 
based on lipophilic sulforhodamine. We looked at the probes toxicity when introduced 
to cells as well as its spectral characteristics. The probe showed cytoplasmic 
74 
 
localisation and has a robust response to T, allowing for quantitative analysis of 
temperature inside single cells.  
 
3.1 Constructing O2-sensing scaffold structures for 3D tissue models 
Scaffold materials are specifically designed to be porous to allow efficient penetration 
of gas and nutrients. They must possess the mechanical strength and structures that 
ensure proper cell growth, adhesion, proliferation, differentiation and migration [291]. 
A prime example is commercially available AlvetexTM, composed of a highly porous 
polystyrene membrane, about 200 µm in thickness and pore size of approximately 36-
40 µm. AlvetexTM scaffolds have prior use in drug screening and toxicity studies [292, 
293], as well as brain and spinal cord tissue explants culturing [294]. They ensure 
structural stability for cell growth, control drug release, allow for measurement of 
mechanical stress and the quantitative measurement of analytes, including the pH 
effect on the metabolic function of chondrocytes [295]  and growth factor release on 
cardio spheres [296].  
Molecular O2 is a key metabolite affecting cell function and viability and must be 
carefully controlled within 3D models [297]. O2 measurements can be achieved by 
coupling the phosphorescent quenching method with solid state sensors or probe 
[227]. Tissue scaffolds potentially allow for the controlled deposition of O2 sensitive 
dye, to produce structures with high brightness and sensitivity to pericellular O2 levels. 
Using a similar approach O2 gradients were measured in engineered tissue using planar 
solid-state phosphorescent O2 sensors [231]. Scaffolds made from electro-spun PLGA 
fibres  with unevenly distributed nanosensors were also proposed for O2 and pH 
detection [298]. Fibre optical micro-sensors have been used to investigate O2 tension 
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in human dermal fibroblasts and human bone marrow derived stromal cells grown on 
collagen type 1 scaffolds [299]. Optical sensors are not invasive nor as unstable as 
electrode systems [234], but the fibre optic probes, needle type micro-sensors [300], 
and planar sensors only allow spot measurement of O2. Fabrication of O2-sensitive 
materials from micro-porous polymeric substrates and their studies by 
phosphorescence lifetime imaging microscopy (PLIM) were recently demonstrated 
[301, 302]. The same approach can be applied to tissue scaffolds based polymers such 
as polystyrene which have moderate O2 permeability [303]. Here we optimised 
staining of a AlvetexTM polystyrene based scaffold with O2-sensitive phosphorescent 
dye PtTFPP, evaluated their O2 sensitivity, compatibility and general uses with 
different cell types and tissue models.    
 
3.1.1 Preparation of O2 scaffolds and their sensing properties  
AlvetexTM is made of polystyrene, which is a popular material for O2 sensor 
production since it provides moderate quenching of embedded phosphorescent 
Pt(II)porphyrins by O2 [303]. The vast network of pores and thin walls facilitated even 
and complete impregnation of dye using the swelling method [304]. This method uses 
the low polarity solvent acetone to ensure dye molecules diffuse into the swollen 
polystyrene [235] (Fig 3.1). The subsequent transfer of the scaffold in the high polarity 
solvent (water) traps the dye molecules in the polystyrene matrix and provides them 
with the required sensitivity to O2. PtTFPP has been shown to have high photo-
stability, brightness and hydro-phobicity. The scaffolds were stained with the optimum 
dye concentration required for fast uniform staining with minimal damage to the 
integrity of the membrane structures. A 70:30 ratio of acetone to water ensured the 
PtTFPP dye dissolved and impregnated the scaffold at 60 oC for 1 h. Other solvents 
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including tetrahydrofurane, acetonitrile and ethanol, were ruled out due to the damages 
in the polystyrene and their inability to completely dissolve the PtTFPP. Washing 
steps ensured excess dye was removed further encouraging uniform staining.  
 
 
Figure 3.1 Dye (Phosphorescent dye PtTFPP) impregnation of AlvetexTM by the 
swelling method.  
 
In such conditions, dye impregnation had no effect on the scaffold structure, with the 
pores remaining the same shape, size and roughness (Fig. 3.2 A) with dye evenly 
distributed throughout the membrane (Fig. 3.2 B). Scaffolds displayed a useful 
sensitivity to O2 across the physiological range 0 %-21 % O2 i.e. 0-209 µM O2. The 
O2 calibration had a hyperbolic dependence of both intensity and lifetime, displaying 
a two-fold reduction at 209 µM compared to zero O2 and curved Stern-Volmer 
intensity and lifetime plots (Fig. 3.2 C, D). The curve indicated non-ideal dye 
distribution, which can be explained by the uneven polystyrene surface and pores 
which when imaged on a wide-field microscope can lead to mild interference of 
lifetime values. The following equation, obtained according to the two-site model 
[305], allowed us to convert lifetime values to O2 concentrations: O2=(0.71108/(-
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1+0.71108+τ/56.5)-1)/0.06414 (R2=0.987). The bright signals allow the scaffold to be 
excited at the 500-535nm, green light spectrum, less harmful to cells when compared 
to the alternative 405 laser.    
 
 
Figure 3.2 O2 scaffolds optical properties (A) Transmission light images of unstained 
and PtTFPP-stained scaffolds. Scale bar unit is in µm. (B) Confocal PLIM image of 
O2 scaffold dye staining, highlighting 3D (left) and 2D projections (right). 3D image 
was produced using 25 optical Z sections of 2µm step width (50 µm). (C) O2 
calibration carried out on wide-field PLIM microscope in intensity and lifetime modes. 
(D) Stern-Volmer plots of O2 calibration and lifetime calibration fitting using the two-
site model (fitting for phosphorescence lifetime is shown). "taken with modification 
from [73]". N=3. 
 
3.1.2 Cell growth and viability in O2–sensitive tissue scaffolds 
We successfully achieved invasion of multicellular aggregates of PC12 cells in 3D 
scaffold, providing a structure on which to attach and ensuring the aggregates were 
surrounded by the O2 sensitive material (Fig. 3.3 A). We observed similar viability and 
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morphology of HCT116 cells in unstained and O2 scaffolds, highlighted with 
fluorescent dyes Calcein green (cytoplasm) and TMRM (polarised mitochondria), 
both on the surface and deeper within the membrane (Fig. 3.3 B, D). Comparable 
numbers of dead cells were also observed in both HCT116 (Fig. 3.3 B [Top]) and 
PC12 cells (Fig. 3.3 B [Bottom]), when stained with CellTox green dye (Fig. 3.3 C). 
Furthermore, PC12 cells retaining viability when cultured for at least 5 days (Fig. 3.3 
B). These results indicate the scaffold staining with PtTFPP dye has no adverse 
toxicity effects on cells, promoting cell growth in the same way as unstained scaffold 
controls. 
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Figure 3.3 Cell viability and growth in O2 scaffolds. (A) 3D reconstruction of PC12 
cells invading the O2 scaffold (B) HCT116 cells in unstained and O2 scaffolds with 
TMRM (20nM, red) and CellTox green(green) [Top], PC12 cells at different times in 
culture (2, 5 days) stained with viable (TMRM) and dead (CellTox green). (C) Number 
of dead cells (CellTox green) and (D) Number of living cells (Calcein) at different 
depths in unstained vs O2 scaffolds (HCT116 WT cells). N=3.  
 
3.1.3 Monitoring oxygenation of different cell types in O2 scaffolds 
The O2 scaffolds were seeded with both individual cells forming a monolayer, 
naturally localising in the top section (5-10 µm depth) of the scaffold and multi-
cellular aggregates that invaded the scaffold to a depth of approximately (50-100 µm). 
When cells were absent the scaffolds displayed phosphorescence lifetimes of around 
21.5-23 µs with very little gradients, maximum 1µs (~5 µM O2) across a 20 µm depth. 
Following HCT116 WT cell seeding (60,000-100,000 density) a monolayer formed on 
the scaffolds surface increasing lifetimes by 2-8 µs (~11-43 µM O2), significant 
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changes when compared to the un-seeded controls (Fig. 3.4 A). No in-depth gradients 
were observed with monolayer cells. PC12 aggregates comprising 10-50 respiring 
cells were seeded on the scaffolds in serum free media supplemented with nerve 
growth factor (NGF), ensuring scaffold invasion. Cell aggregates displayed greater 
lifetime increases compared to the seeding of individual HCT116 monolayer culture. 
Furthermore, there was greater variation at different depths within the scaffold. 
Lifetimes ranged from about 26 µs on the surface (easier access to ambient O2) near 
the cells with significant changes deeper into the scaffold were lifetimes reached as 
high as 36 µs. Using the calibration function, we found that these lifetimes correspond 
to O2 concentrations at around 49-16 µM respectively. Lowest O2 concentrations were 
observed at depths of 10-20 µm, with the highest levels observed on the surface and 
at 40 µm, i.e. the regions usually interacting with the top and bottom portion of the 
aggregates (Fig. 3.4 B). These gradients can be because of increased cell density and 
respiration activity in the core of the aggregate as well as due to limitations in glucose 
and O2 diffusion.  
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Figure 3.4 Changes in oxygenation of HCT116 and PC12 cells across the depth of O2 
scaffolds, measured by PLIM. (A) Lifetime distributions in un-seeded and HCT116 
cell-populated seeded scaffolds. Images of false-colour PLIM superimposed with 
Calcein-stained cells. (B) Combined PLIM (O2) and intensity (TMRM, viable cells) 
images of PC12 cells. Calculated lifetime and O2 concentrations near cell aggregates 
at different depths. Three ROIs were taken in regions near cells, for comparison of O2 
at different depths. Scale bar is in µm. Asterisks indicate significant levels of 
difference with P=0.05 (*) and P=0.005(**). N=3. 
 
3.1.4 Monitoring gene expression changes in scaffolds because of depth-
dependent deoxygenation 
Decreases in O2 availability can lead to PC12 cell differentiation in vitro [306]. In 
hypoxic conditions PC12 cells were seen to increase transcription of tyrosine 
hydroxylase (TH) gene and stabilise its mRNA [307]. We decided to see if the growth 
of cells inside the scaffolds experiencing hypoxia affected the cell differentiation. To 
test this, we seeded 60-100 cell aggregates for 3 days. Following seeding and 
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incubation with the PC12 aggregates in the scaffolds we first monitored the O2 
concentrations at various depths prior to fixation and immunostaining with anti-TH 
antibody. As previously observed the lowest O2 concentrations were at 10-20µm 
depth, which following immunostaining corresponded to highest intensity staining of 
the TH antibody (Fig. 3.5 A, B). Results show that greater cell differentiation occurs 
in more hypoxic regions, a process which can be imaged using these O2 scaffolds.  
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Figure 3.5 Effect of hypoxia on differentiation of PC12 cells. PC12 cells were grown 
in O2 scaffolds, analysed by PLIM and immunostained with anti-TH antibody. (A) 
Superimposed PLIM images (false colour) and TMRM staining (red) (top panel) and 
distribution of TH-positive cells (bottom) measured at various depths. Scale bar is in 
µm. (B) Correlation of TH-positive cell staining and O2 concentration in O2 scaffold 
at different depths. Multiple ROIs were taken for regions near or at cells, at each depth 
for three separate experiments, with examples of chosen regions shown above. N=3. 
 
3.1.5 Metabolic cell stimulation in O2 scaffolds  
To analyse rapid changes in metabolic activity we stimulated the PC12 aggregates 
with FCCP (an un-coupler that activates respiration) followed by Antimycin A, 
(mitochondrial inhibitor of complex III). Addition of each drug led to significant 
changes in phosphorescence lifetimes, measured in the same regions of interest. FCCP 
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increased the lifetime values by approximately 2-4 µs, reflecting the increase in 
respiration activity. These lifetimes returned to resting levels and in some cases 
decreased following Ant-A addition (Fig. 3.6 A). Lifetime values also varied 
depending on cell proximity to the scaffold, with lifetimes decreasing in regions of the 
scaffold far from actively respiring cells (Fig. 3.6 B). The larger aggregates and those 
that invaded completely showed more profound lifetime changes than those on the 
surface or smaller groups of cells. This can be explained by the increased distances 
from atmospheric O2 deeper in the scaffold and the higher mitochondrial activity in 
larger PC12 aggregates.  
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Figure 3.6 Stimulation of cells with drugs affecting cellular respiration in O2 scaffolds. 
(A) Effect of FCCP and Antimycin A. Lifetime changes close to cell aggregates (red 
square). (B) Changes of lifetime with increased distance from the cells, corresponding 
to the orange, red and blue squares in (A) PLIM image. The very same region (red box 
in this case), was chosen to compare, resting, FCCP and AntA treated cells. Scale bar 
is in µm. Asterisks indicate significant levels of difference with P=0.05 (*) and 
P=0.005(**). N=3. 
 
Here we introduced a non-conventional method for measuring cell oxygenation using 
a phosphorescent polystyrene scaffold (AlvetexTM). We accessed the toxicity and 
sensitivity of the PtTFPP O2 sensitive indicator dye. Furthermore, we monitored cell 
oxygenation following seeding with various cell types. Using TCSPC PLIM 
multiplexed with fluorescent markers and immunostaining we correlated lifetime 
values with toxicity, drug stimulation and gene expression. This technique provides 
an efficient, non-invasive method of measuring cell oxygenation within 3D constructs 
via live cell imaging. 
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3.2 Evaluation of conjugated polymer, nanoparticle-based O2 probe 
Nanosensor probes are of great interest due to their small size ensuring they can easily 
enter cells and even sub-cellular compartments, and report on intracellular O2. They 
respond to changes in O2 in real time while the indicator dye is shielded with a 
polymeric shell from possible environmental influences, resulting in stable calibration 
[136]. Their compatibility with confocal, one- and two-photon microscopy is 
advantageous [308]. The SII-0.2+ probe consists of a conjugated polymer functioning 
as a matrix which acts as a light harvesting antenna, a reference (O2-insensitive) 
fluorescent signal, and a backbone to which an O2 sensitive dye is covalently bound. 
The co-polymer is then grafted with charged groups ensuring better cell and tissue 
penetration abilities as well as increased stability. SII-0.2+ has the advantage of being 
capable of both ratiometric intensity as well as phosphorescence lifetime based O2 
measurements, in the visible (one-photon excitation) or near-infrared (two-photon 
excitation) spectral ranges [136]. 
 
3.2.1 Probe characteristics and optical sensor properties 
The measured spectra identified the two peaks, the O2-insensitive reference dye (520-
580 nm) and the O2 sensitive peak (760 nm). Both were measured in ambient O2 and 
following chemical deoxygenation (addition of sulphite). The O2-sensitive peak 
showed a 1.5-fold increase while the reference remained unchanged (Fig. 3.7 A). The 
probe showed efficient staining of monolayer HCT116 cells. Multiplexing with other 
cell compartment markers revealed that the O2 probe was located primarily in the 
lysosomes, displaying strong co-localisation with LysoTracker Red, and absent from 
the cells mitochondria (TMRM) (Fig. 3.7 B). 
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Figure 3.7 Spectral properties of O2 probe. (A) Normalised fluorescence excitation 
and emission spectra in water for different O2 concentrations. (B) Confocal 
fluorescence microscopy of HCT116 cells, stained with O2 probe (5 µg/ml, 16 h) and 
counterstained with LysoTracker Red (Lysosomes, red), TMRM (mitochondria, red). 
Scale bar is in µm.  
 
It is known that the Pt-benzoporphyrins i.e. the O2 sensitive dye in the probe shows 
sensitivity to temperature changes in phosphorescence mode. For this reason, the 
calibration of the probe was carried out at both 37 and 40 oC. We observed that within 
these temperatures, most likely to be the normal range in cells and tissues there was 
practically no significant differences in the calibration equation (Fig. 3.8 A), fitted 
using the two site Stern-Volmer model and the obtained equation: O2=(0.63485/(-
1+0.63485+τ/37.7)-1/0.02486 [242] (Fig. 3.8 B). The lack of significant changes in 
the calibration curve is most likely because of the narrow ranges in which the 
calibration is being carried out. In order to ensure that the O2 probe had no adverse 
effects on cell viability we conducted cell bioenergetics tests, assessing the effect on 
total cellular ATP (Fig. 3.9 A) and extracellular acidification rate (glycolytic flux and 
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Krebs cycle) (Fig. 3.9 B, C) under resting and stressed conditions [309]. Minor toxicity 
was seen for the O2 probe at concentrations greater than 20µg/ml (Fig. 3.9). For this 
reason, working concentrations between 1-5µg/ml was chosen, which showed 
minimal to no toxicity. 
 
 
Figure 3.8 Calibration and Temperature dependency of O2 probe (SII-0.2
+ 
nanoparticles). (A) Intracellular O2 probe calibration produced at 37 
oC and 41 oC. (B) 
Stern-Volmer plot for the O2 probe. 
 
 
Figure 3.9 Evaluation of dose-dependent toxicity for O2 probes in HCT116 cells. Cells 
were stained with the probe at indicated concentration for 17 h and subjected to 
analysis of total cellular ATP and extra-cellular acidification rate (ECAR) under 
sealed (total acidification) and unsealed (lactate-related - glycolytic flux) conditions. 
N=3. Asterisks indicate significance levels of difference with P=0.005 (**). 
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3.3 Sulforhodamine-based temperature-sensitive nanoparticle probe (T probe) 
Temperature is an important factor to be considered in cellular activity as it affects a 
multitude of processes including a cells physical and chemical processes, energy 
production, diffusion of bio-molecules and drugs, acid-base reactions, thus must be 
maintained within definite physiological limits [310-312]. Successful diagnostics and 
disease therapy including cancer treatment are depend upon controlling and imaging 
temperature [313, 314]. Detection of temperature via optical methods such as 
fluorescence allows for live real time imaging of temperature distribution and 
gradients. Attempts have been made to design FLIM-based nanoparticles and small 
molecule fluorescent probes capable of imaging temperatures in the cytosol, 
endoplasmic reticulum and mitochondria [192, 202, 203, 315]. These probes have 
their limitations, including self-aggregation, cross-sensitivity to biological ions and 
molecules leading to miscalculations in T-gradients within cells and tissues [316].  For 
these reasons, it is important to design new cell-permeable T-probes and look at 
possible interferences, as well as its ability to enter the cell, temperature sensitivity in 
FLIM mode and toxicity effects. We turned our attention to the hydrophobic 
sulforhodamine derivative impregnated in cationic nanoparticles via the precipitation 
method (designed by Prof. S. Borisov, Graz University of Technology, Austria). By 
modifying the sulforhodamine with aliphatic hydrocarbon tails the hydrophobicity 
was improved, minimising dye leakage from the nanoparticles as well as preventing 
cross-sensitivity.  
 
3.3.1 Evaluating the cell staining properties and probe toxicity 
The T probe spectra showed that following excitation at around 560 nm it has an 
emission peak at 570-580 nm (Fig. 3.10 A). Results also showed that efficient staining 
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occurred in the HCT116 cells used. The T probe showed prominent diffused staining 
in the cytoplasm with little co-localisation with the endosomal (Cholera Toxin) and 
mitochondrial (Mito-Tracker Green) probes. There was co-localisation with the 
lysosomes (SII-0.2+ and NanO2), with these regions displaying higher staining 
intensities and higher lifetime values compared to the cytoplasm (Fig. 3.10 B). 
Efficient staining was observed with concentrations of 1-2 µg/ml for 16-24 h.   
 
 
Figure 3.10 Spectral properties of T probe and intracellular localisation. (A) 
Normalised fluorescence excitation and emission spectra for T-sensitive nanoparticles 
(25 oC). (B) Confocal fluorescence microscopy of HCT116 cells, stained with T probe 
(1 µg/ml, 16 h red) and counterstained with Cholera toxin (endosomes), O2 probe 
(Lysosomes), Mito-Tracker Green (mitochondria) and NanO2 (another nanoparticle 
probe) (all shown in green). Scale bar is in µm.  
 
Staining of cell monolayer displayed uniform distribution of fluorescence lifetime and 
temperature values (Fig. 3.11), a decay that could be fitted with a mono-exponential 
fit, over the range 2.2-2.8 ns (25-42 oC). A fraction of higher lifetimes indicating lower 
temperatures were found in the lysosomal compartments (Fig. 3.12 A). However 
Lysosomes have a higher acidity compared to the rest of the cell, (pH 4.5-5) and as 
such may be adversely affecting the probe and its lifetime values [280]. For this 
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reason, the lifetimes found in the lysosomes were not used for analysis, taking away 
only a small fraction available for use in each cell (Fig. 3.11). As a control, we used 
free dye (without encapsulation into nanoparticles), which showed similar intracellular 
accumulation. However free dye displayed concentration dependence of lifetime 
values, had a narrower calibration than the nanoparticles indicating decreased 
sensitivity to temperature (Fig 3.12 A, B, D). The T probe i.e. nanoparticles, showed 
a linear calibration in cells very like that measured with the probe in water when 
compared to free dye (Fig 3.12 B, C). 
 
 
Figure 3.11 Evaluation of temperature distribution in adherent (2D). (A) Cells were 
exposed to 37 and 40 oC and measured by FLIM for internal temperature in regions 
indicated by pink dashed lines. (B) Example of a mono-exponential fitting of decay, 
for cells imaged at 40 oC. Scale bar is in the µm.  
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Figure 3.12 The comparison of in cell temperature calibrations for sulforhodamine 
encapsulated in RL100 nanoparticles and in free dye form. (A) FLIM images of 
adherent cells stained with dye or nanoparticles for 16 h at indicated concentrations 
and measured by FLIM microscopy at different temperature. (B) Comparison of in 
cell calibration for sulforhodamine in nanoparticles and in free dye. (C) Fluorescence 
lifetime distribution histogram for nanoparticles. (D) Fluorescence lifetime 
distribution histogram for sulforhodamine dye in free form. Scale bar is in µm. 
 
The T probe was subjected to the same toxicity tests as the O2 probe chapter 3.2. We 
again assessed the effect of nanoparticles on total cellular ATP (Figure 3.13 A), 
extracellular acidification rate (glycolytic flux and Krebs cycle) (Figure 3.13 B, C), 
under resting and metabolic stimulation conditions. The T probe showed no significant 
toxicity for concentrations 1-2 µg/ml following 16-24 h staining in monolayer cells. 
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Figure 3.13 Evaluation of dose-dependent toxicity for T probes for HCT116 cells. 
Cells were stained with the probe at indicated concentration for 17 h and subjected to 
analysis of total cellular ATP and extracellular acidification rate (ECAR) under sealed 
(total acidification) and unsealed (glycolytic flux) conditions. N=3. Asterisks indicate 
significance levels of difference with P=0.005 (**). 
 
The newly developed O2-sensitive porous polystyrene scaffolds and nanoparticle 
probes measuring either O2 or temperature have shown positive results. The O2 
scaffolds provide an excellent platform for 3D culture formation, with a stable O2 
calibration capable of monitoring pericellular O2. They were shown to be non-toxic 
ensuring, cells retain viability, functioning normally when grown on the PtTFPP 
stained membranes. Scaffolds have shown uses in monitoring gene expression via 
immunostaining as well as monitoring oxygenation following metabolic stimulation. 
The intracellular nanoparticle probes allow for live real time intracellular imaging of 
O2 and temperature, monitoring their dynamic changes within cells. They display 
stable calibrations and are immune to adverse effects by external stimuli in the 
physiological ranges of O2 and temperature measured. 
Over all the described sensors and probes provide an excellent option for monitoring 
O2 and temperature gradients and distribution in the cell and small tissues. They will 
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aid research involving the study of the effects of O2 and temperature on gene 
expression, disease progression and morphological studies.  
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Chapter 4. Physiological imaging studies with 3D tissue 
models and new probes 
Abstract 
In this chapter, we first compare three different spheroid methods, looking at size, 
uniformity and viability, determining the best method for a physiologically relevant in 
vivo like model. We were then able to combine our chosen method with our novel O2 
and T probes in several interesting studies. We conducted a drug toxicity study, 
looking at the effect of the anti-cancer drug in both a scaffold based system and 
scaffold free spheroid model. We monitored the toxicity effects of chemotherapeutic 
drug tirpazamine, measuring O2 changes using either our new O2 sensitive scaffolds 
or intracellular O2 nanoparticles. We carried out a metabolic study evaluating T and 
O2 gradients in 3D spheroids using the fluorescent lifetime imaging microscopy 
(FLIM) technique. We found heterogeneous gradients of T and O2 in our spheroid 
model absent in the 2D monolayer. Gradients were enhanced by treatment with 
mitochondrial uncouplers or dissipated by drug induced disaggregation (cantharidin 
led to the destruction of the spheroids tight spherical structure). Finally, we looked to 
elucidate the function of SPCA2, in colon cancer HCT116 cells. We discovered 
SPCA2 was upregulated in hypoxia (3 % O2) in both 2D adherent cells and 3D 
spheroids. Using our intracellular O2 probes we observed O2 concentrations as low as 
30-50µM in our spheroids, measured by phosphorescent lifetime imaging. We also 
noted that cells exposed to hypoxia showed an overall increase in S phase-positive 
cells, hypothesising that SPCA2 upregulation in hypoxia is linked to Mn2+ dependent 
cell cycle arrest. Our results point at an important role for SPCA2 in regulating cell 
cycle progression in cancer cells.  
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4.1 Optimisation of spheroid models 
4.1.1 Spheroid formation methods 
Spheroids are the clusters of cells that self-assemble excreting their own extracellular 
matrix. Tumour spheroids are characterised by gradients in bio-molecules, nutrients, 
temperature and O2 while maintaining similar cyto-architecture to cells in vivo [317]. 
There are numerous methods for spheroid production with the "free floating" culture 
method as one of the most widespread [54]. It relies on culturing cells in serum-free 
media with additional growth factors, FGF and EGF (Fig 4.1 A). This method ensures 
cells do not attach to the cell culture flask, as well as simultaneously encouraging cells 
aggregation. Another method is the use of hydrophobic round bottom wells such as 
LipidureTM plates. These plates have a coating comprised of 2-methacryloyloxtethyl 
phosphorylcholine (MPC), the same structure as polar phospholipids, having a 
hydrophilic nature with minimal toxicity. The phospholipid layer preventing 
attachment to the plate (Fig. 4.1 B).  "Hanging drop" uses gravity force and specially 
designed plates to form spheroids within the meniscus of medium. Cells are suspended 
in a droplet of media ensuring that they have no other option than to aggregate (Fig. 
4.1, C). This method is more expensive and labour intensive compared to "free 
floating" [318, 319]. All the described methods help forming multi-cellular tumour 
spheroids, however we deemed it necessary to further investigate whether there were 
significant differences in the quality of spheroids produced by the different methods 
regarding size, uniformity, metabolic activity and viability [320]. 
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Figure 4.1 Schematic showing the different spheroid formation methods. A. "Free 
floating". (B) LipidureTM. (C) "Hanging drop".   
 
4.1.2 Optimisation of the size and shape of 3D spheroid model using three 
different methods of production 
We compared three different spheroid production methods using HCT116 colon 
cancer cells: "free floating" culture, LipidureTM and "hanging drop", looking for the 
method capable of creating uniform sized spheroids combined with ease of handling. 
The "free floating" culture had the greatest variation in shape and size with little 
possibility for controlling either. Both the LipidureTM and "hanging drop" method 
produced spheroids of more uniform size and spherical shape with excellent 
reproducibility and control (Fig.4.2 A, B).      
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Figure 4.2 Comparison of spheroid sizes for three different formation methods, "free-
floating" formation (FF), LipidureTM and "hanging drop". All spheroids were three 
days old. (A) Transmission light images of spheroids produced by different methods. 
(B) the variation in sizes of produced spheroids. Scale bar is in µm. ***Asterisks 
indicate confidence levels (significant difference) P<0.001. N=3. 
 
4.1.3 Cell viability and proliferation capacity  
We analysed cell death in spheroids formed by different methods using live cell 
viability stains. The CellTox Green stains cells with impaired membrane integrity, 
revealing performance of the production methods (Fig. 4.3 A). The lowest number of 
dead cells were seen in LipidureTM spheroids produced by seeding 3000 cells per well, 
while the cell death was significantly higher for similar sized spheroids produced using 
"hanging drop" (Fig. 4.3 B). Interestingly the number of dead cells increased with size 
of spheroids, thus while cell death results are low for "free floating" culture this may 
be because of the relatively small spheroids formed by this method when compared to 
the other two. Also, since "free floating" method does not allow to control size, the 
cell death variability was high (Fig. 4.3). CellTox informs on cell death caused 
primarily by necrosis. We also compared cell death caused by apoptosis using 
CellEventTM caspase 3/7 substrate. Unlike the CellTox staining there were no 
significant differences because of high variation in apoptotic cell death between 
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methods, but it did follow a similar trend as necrotic cell death, with LipidureTM plates 
showing the highest viability (Fig. 4.4). 
 
 
Figure 4.3 Comparison of cell viability in three different production methods. (A) 
fluorescent intensity of spheroids stained with marker of membrane integrity (CellTox 
Green, 0.2 % v/v, 3 days) and O2 probe (NanO2, 5 µg/ml, 3 days, intensity image). 
Spheroids were 3 days old. (B) the average number of dead cells per typical spheroid 
of 100-500 µm size. Scale bar is in µm. *Asterisks indicate confidence levels 
(significant difference) P<0.05, ***P<0.001. N=3. 
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Figure 4.4 Comparison of apoptotic cell death using three different production 
methods. (A) number of apoptotic cells visualised using CellEventTM caspase 3/7 (2 
µM, 3 days) per typical spheroid of 100-500 µM size. N=3. 
 
We chose the stain TMRM (marker of polarised mitochondria) to label metabolically 
active cells in spheroid culture. Only the periphery showed TMRM staining in pre-
formed spheroids, showing poor penetration of the marker into the core. Highest 
intensity TMRM staining, indicating more active mitochondria, was observed in 
LipidureTM and "hanging drop" spheroids, compared to the "free floating" method 
(Fig. 4.5 A, B). Another indicator of cell vitality is the ability to divide and replicate, 
which can be monitored by incorporation of BrdU (a marker of cell proliferation) 
[321]. Again, the higher number of proliferating cells were seen in the spheroids 
produced by LipidureTM and "hanging drop" methods. The replicating cells were 
located primarily on the periphery of the spheroids with little to no staining in the core 
(Fig. 4.6 A, B). This may explain why the smaller "free floating" spheroids had 
significantly smaller numbers of proliferating cells, due to their much smaller size. 
The final test of cell viability was the analysis of cellular ATP, which showed high 
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viability using the LipidureTM and "hanging drop" methods (Fig. 4.7). Using 
LipidureTM and “hanging drop” it was possible measure the ATP produced by one 
single spheroid (easily transferred to a single well in the 96-well plate), with the small 
standard deviations indicating uniformity in cellular viability per spheroid, using these 
formation methods. The ATP measurements using the "free floating" method were 
difficult as the number of spheroids added to each well varied from 12-18. This made 
it impossible to account for the cellular viability of a single “free floating” spheroids, 
highlighting the methods incompatibility with this measurement technique and 
problems regarding ease of use. These tests served to highlight the importance of 
controlling spheroid size, regarding proliferation and cell viability, an impossible task 
using the "free floating" method, putting it at a great disadvantage to the other two 
methods. 
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Figure 4.5 Assessment of mitochondrial membrane potential in spheroids. (A) 
Representative intensity images of spheroids with live cell staining with TMRM (20 
nM, 30 min) (B) graph showing the average intensity staining values for TMRM. Scale 
bar is in µm. TMRM intensity values were taken from 3 stained regions (ROIs) of the 
spheroids periphery, following imaging at the widest point of the spheroid (What we 
considered to be the centre). This was carried out for 3 separate spheroids per each 
method, combining average staining values. ***Asterisks indicate confidence levels 
(significant difference) P<0.001. N=3. 
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Figure 4.6 Assessment of cell proliferation in spheroids. (A) Representative images of 
spheroids labelled with BrdU (blue). (B) graph showing the average number of BrdU 
stained cells per spheroid. BrdU cells were counting using fiji software at the widest 
point spheroid, what we refer to as our ROI (This Z plane what we considered to be 
the centre of the spheroid). This was carried out for 3 separate spheroids per each 
method, combining average number of BrdU positive cells). On the X axis, 6000 is 
the number of cells seeded per spheroid (For free floating the number of seeded cells 
per spheroid is unknown). Scale bar is in µm. ***Asterisks indicate confidence levels 
(significant difference) P<0.001. N=3 
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Figure 4.7 Comparison of total cellular ATP (CellTitre-Glo assay) by three different 
methods. Luminescent signals of the CellTitre-Glo reagent (Promega) were measured 
on a time-resolved fluorescence plate reader Victor2 (Perkin Elmer) in 96-well plates.  
 
4.1.4 Further evaluation of the LipidureTM method 
The above initial testing showed that LipidureTM was the favourable method in terms 
of viability, ease of handling and uniformity. Thus, we chose this method to carry out 
further experiments. DAPI staining of cell nuclei revealed that cells seeded at a density 
of 1,000 for 3 days had between 2,500 and 3,500 cells per spheroid (counted using 
DAPI staining and “3D objects counter” plugin in Fiji software) and a diameter of 
spheroids in the range of 400-450 µm (Fig. 4.8 A). This provided a calibration relating 
cells seeded and the size of spheroids formed following a set period of time (Fig. 4.8 
B), which is useful when you aim to produce spheroids of a specific size. 
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Figure 4.8 Controlling spheroid size using the LipidureTM method. (A) 3D 
reconstruction of spheroid with DAPI-stained nuclei. (B) Spheroid size dependence 
on the number of seeded cells with LipidureTM method. Scale bar is in µm. 
 
4.1.5 Staining of spheroids with nanoparticle probes and imaging of O2 and T 
gradients 
In chapter 3 we chose O2 and temperature sensitive nanoparticle probes, allowing 
intracellular staining of monolayer culture upon 16-24 h incubation. However, staining 
efficiency often decreases when the 3D tissue model is used instead of monolayer 
cultures [278]. Nanoparticle probes often lack the ability to penetrate the core of the 
structure of 3D cell models and instead stain only a fraction of the periphery (see e.g. 
Figs 4.5, 4.6). When we applied SII-0.2+ nanoparticles to the formed spheroids only a 
small cross-section of the spheroid was stained efficiently, mainly the surface (Fig. 4.9 
B). However, this problem was negated by adding the probe at the very beginning of 
the culturing process, at the cell seeding phase. This method of continuous staining 
ensured excellent staining through-out and uniform distribution (Fig. 4.9 A). In 
contrast, the T probe did not require continuous staining but instead showed deep 
penetration following addition to the media 17h prior to imaging when the spheroids 
were fully formed (Fig. 4.9 C).  
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Figure 4.9 Optimising probe staining in multi-cellular tumour spheroids. (A) Post 
formation staining with O2 probe (5 µg/ml, 17 h). (B) Continuous staining with O2 
probe (5 µg/ml, 3 days). (C) Post formation staining with T probe (1 µg/ml, 17 h). 
 
The aim of 3D tissue models such as spheroids is to mimic in vivo conditions for the 
cells. One aspect of these models is the presence of prominent gradients, which are 
because of different O2 diffusion patterns and uneven distribution of nutrients. 
Following staining optimisation it was possible to image using either PLIM (O2 probe) 
and/or FLIM (T probe) the distribution of the respective analyte. Results showed than 
gradients in both O2 and temperature existed in the Lipidure
TM spheroid model: the 
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lowest O2 values indicated by higher phosphorescence lifetimes were observed in the 
core of the spheroid, with higher O2 concentrations located at the periphery where 
there is less of a barrier to the ambient O2, and lower density of actively respiring cells 
(Fig. 4.10 A). Similarly, the highest temperatures were measure in the core, 
corresponding to the lower lifetime values of the FLIM probe. The difference in 
temperature between the periphery and core was approximately 2-3oC (Fig. 4.10 B). 
We think that such gradients also occur in vivo [322], and that our LipidureTM spheroid 
model can be used for mimicking natural tumour tissue.  
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Figure 4.10 O2 and Temperature gradients in Lipidure
TM spheroids. (A) False colour 
PLIM image of the core of a spheroid (Left) and the corresponding O2 profile across 
the diameter of the spheroid, for the white line, region of interest (Right). (B) FLIM 
false colour image of the cross section of HCT116 spheroid stained with T probe and 
the corresponding graph showing the temperature profile across the spheroid.  Scale 
bar in µm.  
 
Although on the surface spheroids tend to look uniform and similar regardless of the 
method of production we found that they display some intrinsic differences. Using 
fluorescent stains that are capable of monitoring cell death, cell viability, as well as 
shape and size we could select a method of formation which we deemed better for 
physiological studies than the other two options. Furthermore, using this method, we 
could identify further advantages for our tumour model including the ability to predict 
size based on seeding and formation of natural O2 and temperature gradient at resting 
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conditions. The probes were also capable of in-depth efficient staining of our 3D 
tumour model. 
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4.2 Measuring O2 changes following drug stimulation in two different 3D models 
4.2.1 PC12 cell aggregates seeded in O2 sensitive scaffolds 
Hypoxia is a characteristic feature of tumours, thus some new anti-cancer drugs are 
being developed that are effective under low O2 [323]. One promising approach is the 
design of prodrugs that are activated in hypoxic regions. Following accumulation they 
are reduced by reductases and produce free radicals [324]. An example is tirapazamine 
(TPZ) which blocks DNA repair in hypoxic cells [325]. We wondered if TPZ action 
can be studied in PC12 cells grown in O2 scaffolds, with monitored O2 near cells 
(chapter 3.6). To assess cell survival and death, we also employed live cell imaging 
dyes CellTox Green (membrane integrity) and TMRM (mitochondrial tracer) and 
correlating it with cell oxygenation (Fig. 4.11 A, B). The addition of 1 mM TPZ led 
to a significant increase in cell death compared to the control after only 40 minutes. 
The most severely affected regions were at depths of (10-20 µm), with an almost 4-
fold increase in cell death when compared to the DMSO-treated controls (Fig. 4.11 
C). The highest cell death correlated with regions previously measured as significantly 
more hypoxic (20-30 µM, O2), while the lowest was seen at the surface were cells 
have greater accessibility to O2 (Fig 3.4B, Fig 4.11 C). The TPZ was indeed more 
active in hypoxic regions (Fig. 4.11 D), thus the more physiological environment in 
the scaffold ensured TPZ effects are quicker when compared to reported data on A459 
cells (48 h-long treatment) in a micro-fluidic system [326]. Thus, hybrid O2 sensitive 
scaffolds provide a platform on which to measure the effects of hypoxia and drug 
treatment on a mini tumour tissue model. 
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Figure 4.11 Cell death in PC12 aggregates treated with TPZ correlated with in-depth 
O2 gradients. (A) TMRM (red) and CellTox staining of cells treated with 1mM TPZ 
(Top) and corresponding PLIM images (false color). (B) Similar images for control 
(1% DMSO-treated) samples. Scale bar is in µm. (C) Correlation of the number of 
dead cells and (D) O2 concentration at different depths for TPZ-treated and control 
cells. ROIs were chosen near living (TMRM stained) cells for all samples. ROIs were 
chosen near living (TMRM stained) cell aggregates, for control and drug treated 
samples. Asterisks indicate significant levels of difference with P=0.05(*) and 
P=0.005(**). N=3. 
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4.2.2 TPZ treatment of HCT116 tumour spheroids 
Measuring the core region of tumour spheroids using the O2 nanoparticle probe, we 
noticed very low O2 levels, while in cells closer to the periphery concentrations were 
significantly higher due to the proximity to ambient O2 (Fig. 4.10 D). Again, we aimed 
to see whether TPZ had a different effective across the spheroid, like results in our O2 
scaffolds. First the treatment time and concentration of the TPZ were optimised. 
Effects became apparent after 16 h incubation at a concentration of 0.5 mM. 
Incubation times are much longer than with the O2 scaffolds, perhaps due to the 
increase in the size of the spheroids compared to the PC12 aggregates, the different 
cell line, the more compact structure and the lack of pores facilitating drug transport.  
Imaging both TMRM and O2 using SII-0.2
+ showed a decrease in the viability of cells 
near the core of the spheroid correlating with lower lifetime values in TPZ treated 
samples (Fig. 4.12 A, B). Decreased viability was indicated by lower TMRM 
(mitochondrial membrane potential) staining (Fig. 4.12 C), higher numbers of dead 
cells and an increase in O2 concentration (Fig. 4.12 D, E). Higher O2 levels were 
caused by the decrease of viable respiring cells as the drug took effect.  
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Figure 4.12 Monitoring of TPZ action in SII-0.2+ stained HCT116 spheroids. (A, B) 
PLIM images (false color scale) of spheroids treated with DMSO (mock) and TPZ 
(0.5 mM) respectively for 16 h. Spheroids were also stained with TMRM 
(mitochondrial membrane potential, green. (C) TMRM staining for DMSO samples 
vs TPZ samples. (D, E) Measured cell death using CellTox (0.2 %, 3 days) and 
oxygenation via PLIM imaging (SII-0.2+, 5 µg/ml, 3 days) respectively for both 
DMSO and TPZ-treated samples. ROIs were chosen at similar regions for control and 
drug treated samples, avoiding the centre of spheroids, were no measurements were 
possible for drug treated samples, most likely because of dead cells. Scale bar is in 
µm. N=3. 
 
Two different 3D systems one scaffold based (AlvetexTM), the other non-scaffold 
based (spheroids), displayed similar gradients in O2, with lower concentrations 
measured in the core. Both systems proved to be useful in monitoring drug effects on 
a more physiologically relevant model, informing on changes associated with cell 
respiration rate and viability. The anti-cancer drug tirapazamine, effective in hypoxia, 
led to significant increases in cell death in the core of both the scaffold and spheroid. 
Furthermore, increases in O2 were observed as the viability of the cells decreased.  
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4.3 Simultaneous monitoring of Temperature and O2 gradients in tumour 
spheroid 
4.3.1 Measuring dynamic changes in O2 and temperature distribution 
Numerous studies have shown the presence of O2 gradients and other nutrients in 3D 
tissue models. O2 gradients exist in 3D cell aggregates with a diameter greater than 50 
µm [54, 327]. This suggests that gradients in temperature may exist in similar sized 
models. To test this, we multiplexed both the O2 probe and the T probe, measuring in 
real time the O2 and temperature within metabolically active HCT116 spheroids, 
exposed to temperatures of 37 and 40 oC in an incubator. Gradients in the spheroid 
core were observed for both temperature and O2, with higher temperature (2-3 
oC) and 
lower O2 (10-15 µM decrease) levels, when compared to the periphery (Fig. 4.13). Our 
data also showed that the O2 levels were affected by changing temperatures. When the 
external temperature was increased to 40 oC the spheroid core additionally heated up 
to about 41 oC, but it became significantly more oxygenated (Fig. 4.13 D). The reason 
for this decrease in O2 may be due to the changing balance of energy production 
pathways, switching from oxidative phosphorylation to glycolysis, faster diffusion of 
O2 inside spheroids or decreased cell viability as the temperatures rose to critical 
levels.  
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Figure 4.13 Comparison of T and O2 gradients in resting HCT116 spheroids. 
Spheroids were stained with O2 and T probes, exposed to different temperatures and 
measured by FLIM-PLIM microscopy at 0 and 30 µm depths. (A, B) Examples of 
FLIM images of T probe (Left) and PLIM imaging of the same spheroids for O2 probe 
(right).  (C, D) Measured temperatures at the core and periphery of the spheroid at 37 
and 40 oC (left), and measured O2 concentrations for the same regions of the same 
spheroid (right). Three ROIs with values averaged were taken for the periphery (Top, 
surface portion of the spheroid) and the core (30 µm depth at the centre of the spheroid) 
for comparison, per spheroid. The very same regions were taken again following 
changing of the incubator temperature. Scale bar is in µm Asterisks indicate 
significance levels of difference with P=0.05 (*), P=0.001(***). N=3. 
 
4.3.2 Destabilising the 3D structure of spheroids using HSP70 inhibitor 
cantharidin 
To confirm that the spheroid cell density and compact structure contribute to the 
formation of these T and O2 gradients, we attacked it structural integrity, using the 
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drug cantharidin. When the HCT116 spheroids were treated with HSP70 pathway 
inhibitor cantharidin (CAN) they lose the ability to remain as aggregates as well as 
their compact, spherical shape (Fig. 4.14 A, B, C). Using our probes, we compared 
temperature and O2 before and after CAN treatment and spheroid disaggregation. 
Indeed, the loosely bound drug-treated spheroids showed increased O2 levels and 
temperatures, approaching ambient levels, more like monolayer culture (Fig. 4.14 D, 
E, G, H). Spheroid disaggregation was confirmed by transmission light microscopy 
and TMRM staining, highlighting mitochondrial membrane potential. The control 
spheroids show higher intensity TMRM staining, indicating high viability in spheroid 
culture, while CAN led to significantly decreased staining (Fig. 4.14 C, F). As the 
spheroids lost their structural stability the gradients in temperature and O2 began to 
disappear.  
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Figure 4.14. Disaggregation of spheroids diminishes the T and O2 gradients. HCT116 
cell spheroids treated with cantharidin (CAN, 5 μM, 3h) at 37 oC, were analysed. 
DMSO was used as control. A: Transmission light microscopy. B: Staining with 
mitochondrial membrane potential probe, TMRM (20 nM). C: O2 Representative 
PLIM images (top) and calculated mean O2 values (bottom). D: Representative FLIM 
images (top) and average T values (bottom). ROIs were chosen from the periphery for 
comparison i.e. Surface of the spheroid (not in-depth, 0 µm), areas near the outer edges 
of both formed spheroids and disintegrated spheroids, due to there being no inner areas 
for those treated with cantharidin. Scale bar is in μm. N=3. 
 
4.3.3 Effect of metabolic stimulation on gradients of temperature and O2 
HCT116 spheroids were treated with the mitochondrial un-coupler FCCP in 
conjunction with oligomycin (complex V inhibitor), achieving maximal uncoupling 
[223] and increasing respiration. Treatment led to de-oxygenation of spheroids as a 
result of increased O2 consumption following uncoupling, similar to previously 
described reports [283, 328].  The O2 decrease correlated with an increase in 
temperature throughout, with the core showing approximately 2 oC difference 
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following stimulation, in spheroids of 200-250 µm size (Fig. 4.15 A, B). In contrast, 
spheroids produced from non-respiring SCO2-/- cells revealed drastic difference in 
response to uncoupling: no changes in T and O2 were detected. SCO2-/-spheroids also 
displayed core temperature nearly equal to ambient, and higher overall oxygenation, 
compared to wild-type cells (Fig. 4.15 C, D). These results indicate that T gradient in 
HCT116 spheroids is largely dependent upon oxidative phosphorylation and 
mitochondrial membrane potential.  
 
 
 
 
 
119 
 
 
Figure 4.15 The gradients of T and O2 upon metabolic stimulation in spheroids. 
Spheroids were produced from respiring wild-type HCT116 WT (A, B) and OXPHOS 
deficient HCT116 SCO2-/- (C, D) cells stained with T and O2 probes and measured 
by FLIM-PLIM microscopy before and after stimulation (4 µM FCCP, 10 µM 
oligomycin, 10 min). As they are the same spheroid the very same ROIs were chosen 
for resting and following FCCP treated. Scale bar is in µm. N=3. 
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Our results demonstrate that regarding the regulation of both temperature and O2, 3D 
tissue models prove to be a much more physiological compared to conventional 2D 
culturing. This will be of great importance in helping us understand tumour biology, 
aiding in anticancer drug development, as well as improving therapies and 
interpretation of T and O2 effects on metabolism. Our combined imaging of 
temperature and O2 using the FLIM/PLIM method has great potential for applications 
when combined with other tissue models in cancer biology and regenerative medicine.   
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4.4 Ca2+/Mn2+-ATPase, SPCA2 is regulated by O2 availability and affects Mn2+ 
dependent cell cycle progression in colon cancer cells 
SPCA2 is an important  Ca2+/Mn2+ ion transporter located in the membranes of the 
secretory pathway, more specifically the Golgi compartment and endosomes [329, 
330]. It is highly expressed in tissues including the lungs, gastrointestinal tract, 
mammary gland during lactation as well as in some cancer cell lines [281, 329, 331-
333].  SPCA2 has an affinity to Ca2+ comparable to SERCA2, one of the main Ca2+ 
transporting systems while also having the ability to transport and regulate cytosolic 
concentrations of Mn2+ [334]. Several transporter systems including SERCAs, Na+/ 
Ca2+ exchangers and PMCAs ensure the regulation of Ca2+  in eukaryotic cells [335, 
336] maintaining a resting level of 100 nM in the cytosol. Mn2+ transport is controlled 
by manganese homeostasis proteins [337], however to date only a few of these 
transporters have been identified and the understanding of mechanisms of manganese 
homeostasis are not well characterised. Acting as a cofactor to metallo-enzymes 
including oxidases, kinases and DNA/RNA polymerases [337, 338], Mn2+ has the 
ability to scavenge free radicals and regulate ROS formed in hypoxia [339]. Increases 
in the Mn2+ dependant manganese-containing superoxide dismutases (MnSOD) are 
observed in hyperoxia or in regions with high ROS levels [340]. In addition Mn2+ itself 
can act directly as an antioxidant, capable of removing superoxide radicals [341]. The 
transport of Mn2+ is important, considering increased levels of Mn2+ are neuro-toxic 
and are implicated in Parkinson's disease like symptoms [342, 343], high levels are 
also linked to a decrease in GABA concentration in brain through decreasing glutamic 
acid decarboxylase, an enzyme that controls GABA synthesis [344]. Exposure of cells 
to 10-800 µM Mn2+  in medium leads to cell toxicity [336]. Recent studies have even 
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linked cell cycle progression, with MnCl2 exposure causing arrest of cells in G0/G1 
phase in A549 cells [345], while MnSOD has the capability to induce cell arrest [346].  
 
4.4.1 SPCA2 is the only Ca2+ transporting ATPase significantly affected by 
hypoxia and cell density 
SPCA2 is up-regulated in some cancer cell lines, including colon and mammary 
tumours displaying hypoxic regions [347]. To study the expression of SPCA2 we 
chose human colorectal carcinoma HCT116 cells: wild type (WT), with strong 
OXPHOS activity and SCO2-/- knock-out HCT116 cells [284], deficient in OXPHOS, 
experiencing strong oxidative stress under normal conditions. Using semi-quantitative 
reverse transcription polymerase chain reaction (RT-PCR), we analysed expression of 
various Ca2+-ATPase isoforms in these cells. PMCA and SERCA isoforms showed no 
changes in expression in HCT116 WT or SCO2-/- cells when exposed to hypoxic 
conditions (Fig. 4.16). In contrast, we seen an increase in SPCA2 expression, 
confirmed by real time q-PCR in WT cells exposed to hypoxic conditions, while 
SCO2-/- cells had decreased levels of SPCA2 under similar conditions (Fig. 4.17 A, 
B). This is most likely linked to these cells experiencing strong oxidative stress in the 
ambient atmospheric O2 and may be used for Mn
2+ transport and scavenging of ROS 
[284] while  under 3% O2 the SCO2-/- cells would experience less ROS production 
and thus need less SPCA2 activity. In the WT cells active OXPHOS in hypoxia can 
decrease ROS [348, 349], while the increase may be required for the removal of Mn2+ 
no longer required as an antioxidant and for its more efficient intracellular 
sequestering. Changes in cell density also affected SPCA2, with a threefold increase 
in SPCA2 expression observed when cells are grown at 100 % density compared to 
50 % in wild type cells (Fig. 4.17 C). Thus, density is a separate factor affecting 
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SPCA2 expression. To see of hypoxia driven up-regulation of SPCA2 can be 
replicated in vivo we analysed colon tissue samples from mice exposed to continuous 
hypoxia (10 % O2) [282]. Results showed a two-fold up regulation of SPCA2 when 
compared to control mice maintained at normal atmospheric O2 (Fig. 4.17 D).   Results 
conclude that SPCA2 is affected by both environmental O2, in vivo and in vitro, and 
cell density.  
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Figure 4.16: Expression of genes encoding β-Actin, SERCA and PMCA isoforms in 
adherent HCT116 cells (WT and SCO2-/-) grown under normoxic and hypoxic 
conditions and analysed using semi-quantitative RT-PCR using 28 (β-Actin and 
SERCA2b) or 30 cycles (SERCA3, PMCA1 and PMCA4). N=2. 
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Figure 4.17 Expression of genes encoding SPCA2 in adherent HCT116 cells (Wild-
Type, and SCO2-/-) grown under different oxygenation conditions and cell density. 
The average amounts measured via qPCR and normalised to β-actin expression. 
*Asterisks indicate confidence levels (significant difference) of P<0.05, **P<0.05. 
***P<0.001. N=3. 
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4.4.2 SPCA2 expression in 3D tumour spheroids 
We wished to observe whether our results regarding the effect of O2 and cell density 
on SPCA2 expression concurred with monolayer results in a more physiologically 
relevant cell model. Using the PLIM method [278] we analysed O2 gradients in 
spheroids produced using HCT116 WT cells.  Significant gradients were observed 
between the periphery and the core.  Using the NanO2 O2 probe deeper hypoxia was 
seen when the spheroid size was increased through elevated cell seeding in LipidureTM 
plates (Fig. 4.18 A, B). We hypothesised that the O2 gradients as well as the 3D 
architecture of the cells in HCT116 spheroids would influence SPCA2 expression. We 
verified this by using two different sized spheroids with hypoxic cores, followed by 
extraction of total RNA and analysis by real-time PCR. Interestingly a two-fold up-
regulation of SPCA2 expression was seen compared to monolayer cells grown in 
normoxia (Figure 4.18 C). We noticed that the deeper de-oxygenation and cell-cell 
interactions affected expression of SPCA2 in the 3D spheroid model.   
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Figure 4.18 Characterisation of HCT116 spheroids produced by LipidureTM. (A) False 
colour PLIM images of spheroids seeded at 1,000 and 3,000 cells stained with O2 
probe. (B) Mean O2 concentrations at the spheroid surface and in the core (Depth at 
which the spheroids diameter is widest, with the core being the area at centre of the 
spheroid at this depth). (C) Expression of SPCA2 gene in spheroids, seeded at 1,000 
and 3,000 in comparison with normoxic adherent cell culture (50-70 % confluence). 
qPCR data were normalised to β-actin expression. *Asterisks indicate P<0.05, 
**P<0.005. Scale bar is in µm. N=3. 
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4.4.3 SPCA2 expression correlates with MIST1 and is dependent on HIF-1α 
The regulation of SPCA2-encoding gene ATP2C2 have not been well studied. We 
wished to look at how hypoxia affects the transcription factor MIST1, previously 
shown to regulate SPCA2 expression, more specifically a ~20 kDa C-terminal 
fragment in the salivary gland and pancreatic acinar cells [350, 351]. It functions by 
forming a homodimer complex activating gene expression, and is located in the 
nucleus [352]. MIST1 expression was seen to overlap with SPCA2 expression in 
salivary glands, secreting cells of the stomach, prostate and seminal vesicles. MIST1 
expression in HCT116 WT cells and SCO2-/- cells had similar patterns (Fig. 4.19 A, 
B). Interestingly, expression of MIST1 increased with cell density, and in the 
spheroids model (Fig. 4.19 C). The increase of SPCA2 and MIST1 in hypoxia also 
indicated that the hypoxia-inducible factor (HIF) pathway may regulate it. Following 
exposure of cells to CoCl2 (an inhibitor of HIF1α degradation) and DMOG (prolyl-4-
hydroxylase inhibitor/ upregulator of HIF) we seen a 1.5-2 fold increase in both 
SPCA2 and MIST1 expression (Fig. 4.19 E, F, G, H, I). This indicates that their 
expression is most likely regulated via HIF-1α pathway and these genes are its novel 
downstream targets.  
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Figure 4.19 Expression of gene encoding MIST1 in monolayer HCT116 (WT and 
SCO2-/-) cultures grown under normoxic and hypoxic conditions (A, B), at different 
cell densities (C) and in spheroids seeded at 1,000 and 3,000 cells (D). MIST1 and 
SPCA2 gene expression in untreated and CoCl2 treated HCT116 WT cells (E, F). The 
average qPCR values were normalised to β-actin expression. (G) SPCA2 gene 
expression in DMOG treated HCT116 WT cells. (H, I) HIF1α stabilisation in 
untreated, CoCl2 (100 µM, 7 days) and DMOG (1 mM, 2 h) treated HCT116 WT cells. 
*Asterisks indicate P<0.05. N=3. 
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4.4.4 SPCA2 is involved in regulation of cytosolic Mn2+ 
Both Ca2+ and Mn2+ transport is linked through their shared use of secretory pathway 
Ca(2+)-ATPases (SPCA) transporters [353, 354]. Thus, we had a look at the correlation 
between both Ca2+ and Mn2+ with O2. Ca
2+ is an important second messenger, involved 
in the signal transduction process required for cell growth, differentiation, 
proliferation and apoptosis. Prolonged exposure to elevated Ca2+ can lead to 
proliferation and tumour growth [355]. Using the Oregon green BAPTA-1 (OGB) 
probe it was possible to produce a calibration of Ca2+ concentrations versus lifetime 
values of the probe in FLIM mode. 
Applying the OGB probe and multiplexing it with the NanO2 phosphorescent probe it 
was possible to correlate O2 and Ca
2+ concentrations. Results showed that as O2 
increased Ca2+ levels decreased (Fig. 4.20). In the core of the spheroids previously 
seen to be more hypoxic than the periphery there was an increase in Ca2+ concentration 
(Fig. 4.20 B). A possible explanation for this based on previously shown data is that 
in hypoxia both extracellular and intracellular pH decreases leading to an influx of 
Ca2+ [356]. The increase in SPCA2 may be as a result of the need for increased Ca2+ 
within the core of the spheroids which has a more acidic pH than the periphery [357]. 
When comparing HCT116 SCO2-/- and WT spheroids we see no significant changes 
in Ca2+ concentrations in regions of similar O2 levels (Fig. 4.20 C, D, E, F). In contrast 
to WT spheroids there are no Ca2+ gradients in the HCT SCO2-/- spheroids between 
the periphery and the core (Fig. 4.20 B). However similarly there were no O2 gradients 
seen when measuring similar sized SCO2-/-spheroids using the NanO2 probe, a stark 
contrast to gradients seen in HCT116 WT (Fig. 4.18 A, B). From the above results we 
show there is little or no difference in Ca2+concentration between WT and SCO2-/- 
spheroids. However, there are significant differences in SPCA2 expression between 
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the two cell lines. This would indicate that the increased SPCA2 a Ca2+/Mn2+ 
transporter in WT cells in hypoxia is having little effect on Ca2+ transport but is as 
previously hypothesised involves primarily in the transport of Mn2+. 
 
 
Figure 4.20: Measuring intracellular Ca2+ levels in HCT cells. (A) Spheroid stained 
with Oregon green BAPTA-1 (OGB), 20X objective. (B) Ca2+ concentration in 
HCT116 WT and SCO2-/- spheroids. (C, D) OGB staining in HCT116 WT spheroid, 
63X objective, with corresponding graphs showing O2 and Ca
2+ concentration for the 
blue and red ROI. (E, F) OGB staining in HCT116 SCO2-/- spheroid, 63X objective, 
with corresponding graphs showing O2 and Ca
2+ concentration for the blue and red 
ROI. N=3. 
 
Since SPCA2 showed the most dramatic change, and as a result of its role in the 
regulation of intracellular Mn2+ [337] it was necessary to look at the effect of cells 
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over expressing SPCA2 on Mn2+. Mn2+-dependent activity of SPCA2 was 
demonstrated before, however we wanted to confirm if it regulated Mn2+ in cultured 
HCT116 cells. To do this we used the fluorescent biosensor constructs based on the 
GPP130 protein, allowing detection of increase of cytosolic Mn2+ in live cells [290]. 
Increased Mn2+ leads to translocation of GPP130-GFP to lysosomes for degradation 
(Figure 4.21). 
 
 
Figure 4.21 Schematic displaying the method of action of the GPP130 probe. 
 
We transfected cells with plasmid DNA expressing full-length SPCA2 and SERCA2b 
(Fig. 4.22) both with and without the addition of external Mn2+, and quantifying 
regions of interest for GPP130-GFP co-localised with lysosome marker LysoTracker 
Red (Figure 4.23). The addition of Mn2+ alone did not lead to statistically significant 
change in lysosomal translocation of GPP130, whereas overexpression of SPCA2 
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showed its decrease. By combining SPCA2/ Mn2+, a decrease in lysosomal 
translocation occurred.   
 
 
Figure 4.22: Confirmation of over-expression of SPCA2 and SERC2b in cultured 
HCT116 cells. Transfected cells were fixed and immunostained with the antibodies. 
Alexa Fluor-594 conjugated secondary antibodies were used to ensure no signal 
overlap with the GFP-fluorescent GPP130 protein. Antibody staining is shown in 
green, nuclei are shown in blue. Scale bar is in µm. 
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Figure 4.23 SPCA2 overexpression decreases cytosolic Mn2+ and increases ROS 
production. (A) Transmission light and fluorescent image showing HCT116 WT cells 
transfected as indicated and co-stained with LysoTracker Red. Co-localisation of 
GPP130 (Green) with lysosomes (Red) positively correlates with Mn2+ levels. (B, C) 
Results of quantification of translocation of GPP130-GFP in lysosomes, under 
different conditions shown above. *Asterisks indicate confidence levels (significant 
difference) of P<0.05, **P<0.005. Scale bar is in µm. N=5. 
 
4.4.5 SPCA2 is involved in the regulation of Mn2+ -dependent cell cycle 
progression  
The increase of SPCA2 with cell density hinted at the link between its function and 
progression of cell cycle. To test this, we looked at the differences in proliferation in 
cell cultures exposed to hypoxia (3% O2). BrdU staining showed twice the number of 
cells entering S phase during hypoxia when compared to normoxic conditions (Fig. 
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4.24 A, B). This data correlates with increased SPCA2 in hypoxia and its involvement 
in Mn2+ transport. It was previously shown that Mn2+ can arrest the cell cycle in G0/G1 
and S phase [345]. We confirmed this using transfected cells with SPCA2 and 
SERCA2b (control), treated with high MnCl2 in the media, comparing number of cells 
in S phase (Fig. 4.24 C). There was significantly lower cell proliferation in non-
transfected cells, however an increase in the SPCA2-transfected cells (both treated and 
non-treated samples) (Fig. 4.24 C, D). This data confirms that transport of cytosolic 
Mn2+ by SPCA2 prevents cell cycle arrest by this ion. The exact mechanism for 
SPCA2-mediated transport is unclear but should involve sequestering the Mn2+ from 
cytoplasm to Golgi or other compartments and thus decreasing its inhibitory effect on 
cell proliferation. However, such an effect highlights a role in SPCA2 for colon cancer 
cells in their adaption to hypoxia, preventing cell death, increasing proliferation and 
promoting tumour growth.   
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Figure 4.24 SPCA2 restores cell cycle arrest induced by Mn2+. (A, B) Effect of 
hypoxia on percentage of S-phase-positive cells, revealed with BrdU 
immunofluorescence staining. Cells were exposed to hypoxia, pulsed with BrdU (100 
µM, 30 min), and immunostained with anti-BrdU antibody (green). DAPI staining 
(blue)shows nuclei. Scale bar is in µm. (C) Effect of Mn2+ treated and untreated 
HCT116 WT cells on S phase positive cells at 21 % O2. D: Effect of exposure to Mn
2+ 
(0.5 mM, 24 h) on the number of S phase-positive cells in non-transfected and 
SPCA2/SERCA2b- transfected HCT116 cells at ambient (21 %) O2. "taken with 
modifications from [317]". N=3. 
 
In this study, we made several novel discoveries, including the fact SPCA2 expression 
in HCT116 WT cells is dependent upon cell density and de-oxygenation.  We were 
further able to correlate SPCA2 up-regulation with the expression of the transcription 
factor MIST1 and with HIF1α. Evidence indicates that SPCA2 is crucial for Mn2+ 
transport from the cytosol. This is of interest when we consider that SPCA2 plays a 
direct role in the proliferation capacity of HCT116 WT cells, possibly through 
minimising the exposure of the cells to high cytosolic Mn2+.  
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5. General Discussion 
We first introduced a novel approach for measuring changes in extracellular O2 in 3D 
cell and tissue cultures, using phosphorescent O2-sensitive scaffolds coupled with 
confocal microscopy. These hybrid scaffolds proved to be non-invasive, easy to 
manufacture, could retain the cell culturing abilities of the original material, don’t 
require the addition of foreign substances into the cells and produce high fluorescent 
signals. Most importantly for our studies they showed the required sensitivity for O2 
in the physiological range (0-21 % atmospheric O2 or 0-200 µM dissolved O2). This 
protocol can act as a template for future developments, as the success of our particular 
scaffold could be reproduced, using scaffolds made from other materials, containing 
other O2 indicators, including metalloporphyrins [120], providing high sensitivity in 
lower O2 values, infra-red shifted or two-photon excitable using this method. Much 
like planar O2 sensitive coatings [358] our hybrid scaffolds allowed for the monitoring 
of local O2 levels, displaying similar results to previous work, were local micro 
gradients formed because of the highly respiring cells [359]. Using PC12 aggregates 
with approximately 10-50 respiring cells, the gradients in O2 that we observed were 
expected [283]. To analyse rapid (1-5 minute) changes in metabolic activity, we 
stimulated PC12 aggregates with protonophore FCCP (uncoupler that activates 
respiration) and AntA (mitochondrial inhibitor) [297]. Strongest effects of cell 
respiration on O2 measured by the scaffold were near metabolically active cells. It is 
known that low levels of O2 lead to PC12 cell differentiation in vitro. Showing similar 
results to previous work carried out in PC12 cells, our scaffolds were used to monitor 
the increase in transcription of the tyrosine hydroxylase gene and stability of TH 
mRNA in hypoxia [307]. However in contrast to work completed by (O’Driscoll et al, 
2005) [306] no neuritis was seen in the PC12 cells in any regions of the scaffold 
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regardless of O2, explained by different cell morphology in 3D culture, with our 
scaffolds proving to be a useful tool in studying this process via imaging. Hypoxia is 
a common characteristic in tumours, as such drugs are being developed that act 
specifically under such conditions [323]. One mechanism of action involving these 
pro-drugs not active in normoxia, is their accumulation in hypoxia were they are 
reduced by cellular reductases producing toxic free radicals [324]. Tirapazamine 
functions by preventing DNA repair in hypoxic conditions [325] and was previously 
used to study its effects in A549 cells under hypoxic conditions [326]. We studied TPZ 
action at different oxygen levels, as a result of the naturally forming gradients in both 
our scaffolds and in 3D spheroids. In both models, results confirmed that TPZ was 
more active in regions of greater hypoxia within our cancer cells, displaying 
significantly higher cell death, while our O2 scaffolds and intracellular probe could 
inform on changes in O2 associated with cell respiration rate and viability. These 
scaffolds carry out a similar role to fibre optic probes and planar O2 sensors [227]. 
However, the microporous scaffold we produced had its advantages including, 
compatibility with confocal microscopy allowing for high resolution 3D mapping of 
O2 distribution, rather than simply point or 2D measurements. This method also allows 
for O2 detection to be easily multiplexed with other fluorescent probes and markers of 
cellular function widely used in live cell imaging and immunostaining.  
In contrast to our oxygen sensitive scaffolds our novel O2 sensitive conjugated 
polymer nanoparticles can measure intracellular O2, entering cells via endocytosis. 
They have a size of approximately 50 nm, similar to previous O2 nanoparticles 
produced [250].  Furthermore these probes are compatible with one- and two-photon 
excitation as well as both ratiometric (intensity) and lifetime based imaging modes 
[136]. Measuring our probes spectra showed that it has a green residual emission from 
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poly(fluorene-alt-benzothiadiazole) and NIR emission from Pt(II)-benzoporphyrin. 
The use of probes emitting longer red and infra-red-shifted aids in deeper light 
penetration and as a result the ability to measure larger cell based 3D models in excess 
of 150-200 µm [135]. Our nanoparticle efficiently stained monolayer HCT116 cells 
after incubating in the media for 16 h, localising to the endosomes and lysosomes, 
similar to previously described probes like MM2 and PA2 [360, 361]. It showed 
sufficient sensitivity to O2, capable of measuring across the physiological range (0-
200 µM O2). The toxicity of nanoparticles was evaluated by loading of our HCT116 
cells with nanoparticles for 17 h at different concentrations, analysing total cellular 
ATP and extracellular acidification [309]. Only minor toxicity was observed when 
concentrations of greater than 20µg/ml were used, ensuring that at our working 
concentration of 1-5 µg/ml was compatible with live cell imaging. Compared to 
previous probes our new conjugated nanoparticle showed higher brightness, improved 
ratiometric responses and an ability to be easily modified as a result of their chemical 
makeup.  
We also characterised a newly designed T probe, produced using a sulforhodamine 
dye in a cationic RL100 nanoparticle, and show how it is useful in the quantitative T 
imaging in cell and tissue models using FLIM. Rhodamine derived dyes have high 
brightness with fluorescence in the orange-red spectral range (550-700 nm) and robust 
sensitivity to temperature in both intensity and lifetime imaging modes [362, 363]. 
Comparable to previous dyes embedded in polymeric or silica nanoparticles, which 
prevented dye interference from external species [191], the encapsulation of the dye 
inside the polymer ensured that environmental stimuli like pH, serum proteins or ionic 
strength had little to no effect on the probe, while retaining its sensitivity to 
temperature in fluorescent lifetime. Furthermore it showed a decrease in fluorescent 
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lifetime of ~0.6ns between 25-40 oC, a range which can be reliably resolved on modern 
TCSPC-FLIM microscopes [116, 173].  The probe ensured efficient staining of 
HCT116 cells in both monolayer culture and in 3D following addition to growth 
media. The staining and intracellular localisation was comparable to another RL100-
based O2-sensitive NanO2 probe [364], but with greater diffused cytoplasmic staining, 
possible due to the smaller size of the probe (~10nm). This diffused staining was a 
benefit when monitoring temperatures in single cells. The chemical structure of the 
sulforhodamine is very like that of SR101 [365], indicating that the T probe is 
compatible with two-photon FLIM. Using 2D monolayer cell culturing with our T 
probe we seen that there was an almost homogenous distribution of temperature across 
the cytoplasm. Previous work has shown that gradients in temperatures between the 
nucleus and cytoplasm may exist [192], in contrast to our results in monolayer cells. 
However these gradients between the cytoplasm, nucleus have been disputed, due to 
the cells inability to generate such amounts of heat as well as taking into account heat 
dissipation rates [189, 316]. When the probe was added to 3D spheroid cultures 
heterogenous temperatures were measured, with gradients changing depending on size 
and metabolic activity. The spectral and decay characteristics allowed for it to be 
multiplexed with our phosphorescent, intracellular, O2 sensitive nanoparticles. Similar 
heterogeneity was seen with O2 levels. O2 gradients while negligible in individual 
cells, are observed in aggregates and spheroids which reach sizes of greater that 50µm 
[327, 366]. While O2 gradients have been described in relation to spheroids previously 
[278, 283] this was the first time temperature gradients were demonstrated. Previous 
work investigated whether gradients existed in spheroids formed using HeLa cells 
[367], however none were detected, probably as a result of the small size of the HeLa 
spheroids coupled with the fact the cells are highly glycolytic with a low metabolic 
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activity. Our results highlighted the interdependence of temperature and O2 gradients 
in tumour spheroids, with both being effected by the surrounding microenvironment 
as well as the cells metabolic state. We found that the temperature of the spheroid 
never exceeded ~41/42 oC, explained by the adaption of cells to heat produced via their 
metabolic activity, decreasing their heat production and activating their heat shock 
pathway. In cancer cells, they must adapt to ensure excess heat isn’t produced, leading 
to heat shock and cell death. The increase in O2 levels measured in the spheroids core 
when exposed to temperatures of 40 oC, may be as a result of reduced consumption 
and faster diffusion of O2 and the change in utilising of energy production pathways, 
switching from OxPhos to glycolysis [223]. The decrease in O2 may also be as a result 
of decreased cell viability under such high temperatures. The increase in O2 was in 
contrast to the results observed for the temperature dependence of O2 in the aqueous 
phase, differences that are accounted for by cell metabolic activity and viability [368].  
To investigate whether gradients were caused by spheroids formation we treated the 
spheroids with cantharidin [369], decreasing the cell-cell interaction causing 
disaggregation. When they disassembled the O2 levels increased and the temperatures 
approach ambient levels. We also investigated the effects of  metabolic stimulation in 
both HCT116 WT and SCO2-/- cells deficient in  oxidative phosphorylation [284], 
treating cells with FCCP (uncoupler, activates cell respiration) and oligomycin 
(inhibits ATP synthase) achieving maximal mitochondrial uncoupling [223]. In WT 
spheroids there was a significant increase in deoxygenation as a result of O2 
consumption [283], with a concomitantly increase in spheroid temperatures. In 
contrast non-respiring SCO2-/- cells showed no changes in O2 or temperature. The 
SCO2-/-  cells also showed higher O2 levels and near ambient temperature in the core 
linking temperature and O2 gradients in spheroids to oxidative phosphorylation . In 
142 
 
conclusion tumour spheroids were used successfully to observe the dynamics of O2 
and temperature, dependent on structural integrity, spheroid size, viability and 
mitochondrial activity.  
Our O2 probes proved to be useful in a mechanistic study involving the Ca
2+/Mn2+ -
transporting SPCA2 pump. We discovered that SPCA2 expression in HCT116 cells is 
dependent upon both cell density and cell deoxygenation. This was in line with 
previous work which also showed increased expression in a number of colon and 
mammary tumour cell lines [347].  Furthermore, rapidly proliferating cancer cells 
have also been identified in deoxygenated regions [370].  For our study we chose 3% 
O2 as hypoxia, a realistic concentration of O2 to mimic the conditions of the intestine 
in vivo [371], with colon tissues and tumours in vivo displaying heterogeneous O2 
levels ranging from 0 to 5 % [255, 256]. We wished to compare SPCA2 expression in 
2D monolayer culture with a more physiologically relevant spheroid model, 
displaying gradients in O2 and other nutrients. Due to the fact the different methods of 
spheroid formation affect size, metabolic activity and viability [320], we first 
optimised and compared methods of spheroid formation using “free floating culture”, 
LipidureTM, and “hanging drop” [54]. We aimed to find the spheroid production 
method with the most uniform size, viability, with physiologically relevant O2 
gradients as well as being easy to culture. The LipidureTM method proved to be the 
most uniform, with comparable viability, proliferation capacity size and shape noted 
between individual spheroids. It also the easiest method of formation in terms of ease 
of handling. Spheroids produced using HCT116 cells and our chosen formation 
method showed deep deoxygenation after 3days as a result of active mitochondrial 
respiration similar to previously published work [324]. Using our intracellular 
nanoparticle probes we could link hypoxia within spheroids with an increase in 
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SPCA2 expression. We observed an SPCA2 increase in 3D spheroids comparable to 
cells grown in 2D at 3% O2. In order to identify what was regulating SPCA2 in 
HCT116 cells we next analysed MIST1 a transcription factor of the B family of basic 
helix-loop-helix (bHLH), previously shown to regulate SPCA2 expression [350]. 
Because SPCA2 expression increased under hypoxia it may also be regulated by the 
hypoxia-inducible factor (HIF) pathway. To examine this we added well known 
inhibitors of HIF-1α degradation, cobalt chloride and dimethyloxalylglycine (DMOG) 
[370] to the cells, and looked at SPCA2 and MIST1 expression. Both drugs increased 
expression of both SPCA2 and MIST1 nearly 1.5-2-fold indicating they are likely 
regulated by the HIF-1α pathway. Considering SPCA2 is a transporter of both Ca2+ 
and Mn2+ we looked at whether changes in expression led to differences in these ions. 
The lack of any significant differences in intracellular Ca2+ between HCT116 WT and 
SCO2-/-, cell types with significant differences in SPCA2 expression, led us to believe 
the role of SPCA2 in hypoxia was primarily related to manganese transport. Our 
studies into the role of SPCA2 in manganese transport from the cytosol to the golgi 
are in line with previous work involving the ion transporting properties of this enzyme 
[334, 347]. Using the fluorescent biosensor GPP130-GFP we could link SPCA2 with 
the transport of Mn2+ from the cytosol of the cell to the golgi and other secretory 
vesicles.  The effect cell density on SPCA2 expression indicated a possible link 
between the function of this pump and cell cycle progression. Previous work has 
already shown that manganese has the ability to affect cell cycle progression via 
MnSOD [372], decreasing cell proliferation. Our experiments using cells 
overexpressing either SPCA2 or SERCA2b (control), elucidated the role of SPCA2 in 
transport of manganese out of the cytosol, preventing cell cycle arrest by this ion. The 
exact mechanism isn’t known; however, it shows the role of SPCA2 in colon cancer 
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cells. For their adaption to hypoxia, preventing cell death and promoting tumour 
growth. 
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6. Overall conclusion 
Sensing of physiological parameters of the cell and tissue models is of critical 
importance for various applications, analytical platforms and disease models. This 
thesis presents several new sensor and probe systems capable of measuring O2 and 
temperature in fluorescence imaging mode, particularly PLIM and FLIM, and 
displaying their uses in various applications.  
The development of a new hybrid, multi-functional tissue scaffold system produced 
by staining commercial porous polystyrene membrane scaffolds, AlvetexTM with the 
phosphorescent dye PtTFPP using the swelling method enabled us to measure 
oxygenation of HCT116 and PC12 grown on such scaffolds. We can also monitor the 
effects of drug stimulation, including inhibitors and stimulators of respiration, imaging 
the dynamic changes in extracellular O2. Furthermore, O2 levels can be linked or 
correlated with changes in gene expression in the seeded cells and aggregates, a 
process easily monitored via confocal FLIM-PLIM imaging paired with 
immunostaining.  
The novel cell-penetrating O2 and temperature-sensitive nanoparticle probes we 
designed and evaluated for imaging in 3D tissue models. They are capable of efficient 
staining of various types of mammalian cells, with no adverse effects on cell viability 
and function. Excellent probe photostability, brightness, stable calibrations and 
responses to their respective analytes and changing environmental conditions were 
obtained. The nanoparticle probes were also able to penetrate and measure gradients 
in our in vitro 3D tumour spheroid models (some greater than 500 µm diameter), 
dimensions well above the limits of light microscopy.  
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Imaging approach was applied for detailed analysis and comparison of three 
commonly used spheroid formation methods, "free floating", "hanging drop" and 
"LipidureTM". Our spheroid model was optimised to ensure uniformity in size and 
shape in a more physiologically relevant model, displaying natural gradients in O2 and 
temperature, proliferating and dying cells and active mitochondria. Using viability 
probes and proliferation dyes multiplexed with our O2 probe, we could identify the 
formation method which produced the most viable spheroid. 
Combining the sensors and probes with our tissue models, such as scaffolds, cell 
aggregates and tumour spheroids, we could monitor drug effects on cells within a 3D 
microenvironment in two different models, proving they may have a use in future drug 
toxicity studies. The potency of the anti-cancer drug tirapazamine was apparent in the 
more hypoxic regions of both our 3D scaffold model and tumour spheroids. 
Furthermore, we could monitor in real time the concentration and dynamic changes in 
O2 within spheroids following adaption to external stimuli. The ability to carry out live 
cell fluorescence imaging to monitor the dynamics of O2 and temperature, particularly 
by multiplexed PLIM/FLIM method, will further our knowledge of the 3D 
microenvironment in cell and tissue function. The probes were used in a mechanistic 
study (function of Ca/Mn-transporting SPCA2 protein), monitoring changes in gene 
expression in response to O2 changes. The importance of monitoring and knowing O2 
concentration was apparent in the up regulation of SPCA2 because of O2 and cell 
density. The link between hypoxia and changes in O2 regulation led us to discover the 
role SPCA2 plays in the cell cycle, preventing cell arrest through the regulation of 
cellular Mn2+.  
In summary, we have developed new techniques and evaluated new probes which can 
be used for high-resolution live imaging detection of O2, temperature and other 
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important physiological parameters of cell and tissue models. They have proven to be 
instrumental in the improvement of our understanding of the 3D microenvironment, 
gene expression and drug effects in cell and tissue function as well as being 
indispensable in viability studies via live cell microscopy imaging.    
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7. Thesis outcome 
Peer reviewed papers: 
Jenkins J, Borisov SM, Papkovsky DB, Dmitriev RI. Sulforhodamine 
nanothermometer for multi-parametric FLIM imaging. Analytical Chemistry. 
Manuscript submitted. (Chapter 3 and 4) 
Jenkins J, Papkovsky DB, Dmitriev RI. The Ca2+/Mn2+-transporting SPCA2 pump is 
regulated by oxygen and cell density in colon cancer cells. Biochemical Journal 473, 
no. 16 2016: 2507-18. (Chapter 4) 
Fomin M, Dmitriev RI, Jenkins J, Papkovsky DB, Heindl D, König B. A Two-
Acceptor Cyanine-Based Fluorescent Indicator for NAD(P)H in Tumor Cell Models. 
ACS Sensors, 2016: p702-709.  
Jenkins J, Dmitriev RI, Morten K, McDermott KW, Papkovsky DB. Oxygen-sensing 
scaffolds for 3-dimensional cell and tissue culture. Acta Biomater. 2015;16:126-35. 
(Chapter 3 and 4) 
 
Book Chapter: 
Jenkins J, Dmitriev RI, Papkovsky DB. Imaging Cell and Tissue O2 by TCSPC-
PLIM. In: Advanced Time-Correlated Single Photon Counting Applications. Ed. W. 
Becker, Springer International Publishing; 2015. p. 225-47.  
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Published conference proceedings:  
Dmitriev RI, Jenkins J, Okkelman IA, Papkovsky DB. Multi-parametric imaging of 
oxygen in scaffold-free and scaffold-based three-dimensional tissue models. European 
Cells and Materials 2016; p245: Vol. 31. Suppl. 1. (Chapter 3 and 4) 
Jenkins J, Dmitriev R, Papkovsky D. The Secretory Pathway Ca2+/Mn2+-Atpase 
SPCA2 Regulates Mn2+-Dependent Cell Cycle Progression in 3D Culture of Colon 
Cancer Cells. Biophysical Journal 2016;110:336a. (Chapter 4) 
Jenkins J. Local O2 Gradients in Porous 3D Scaffold Monitored by Phosphorescent 
Lifetime Imaging Microscopy. Biophysical Journal 2015;108:484a. (Chapter 3) 
Dmitriev RI, Borisov SM, Jenkins J, Papkovsky DB. Multi-parametric imaging of 
tumor spheroids with ultra-bright and tunable nanoparticle O2 probes. SPIE Proc., 
2015, p. 932806-932808. (Chapter 4) 
 
Conference presentations: 
Oral presentation: "Luminescence lifetime imaging microscopy of temperature and 
O2 gradients in 3D tumour cell model".  Microscopy Society of Ireland, 40
th Annual 
Meeting. Dublin Institute of Technology, Dublin, Ireland. 8th-10th June 2016. 
Poster presentation: "O2 Imaging in 3D cancer cell aggregates: Optimising spheroid 
models, studying drug responses and revealing new physiological roles of SPCA2 
pump". Biophysical Society, 60th Annual Meeting.  Los Angeles United States. 
February 27th-March 2nd 2016.  
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Oral presentation:  "Assessment of cancer cell oxygenation in three dimensions by 
PLIM microscopy". IPIC, Photonics Ireland.  Cork, Ireland. 2th-4th September 2015. 
Oral presentation: "New Systems for Oxygen Imaging in Tissues".  Microscopy 
Society of Ireland and Scottish Microscopy Group - Glasgow, UK.  November 27th-
28th 2014. 
Poster presentation: "O2 Imaging of Biomaterials in 3D porous Scaffolds".  9th 
Workshop on Advanced Multi-photon and Fluorescence Lifetime Imaging 
Techniques. FLIM.  Saarbruecken, Germany.  May 27th-28th, 2014. 
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